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2 Introduction 
DNA and RNA can be methylated by a broad variety of methyltransferases. The best 
studied of these methylations is the methylation at position 5 in cytosine bases that is 
carried out by DNA or RNA m5C methyltransferases. 
 
2.1 Cytosine methylation 
2.1.1 DNA methylation 
The first evidence for methyl groups in DNA was found in calf thymus DNA 
(Hotchkiss 1948). The significance of this DNA modification was discussed 
controversially for quite a while, but nowadays DNA methylation is established as a 
key epigenetic process that is involved in the control of gene expression (Lande-
Diner et al. 2007), imprinting (Delaval and Feil 2004; Hore et al. 2007), X-
chromosome inactivation (Chang et al. 2006) and maintenance of genome integrity 
through protection against mobilization of retrotransposons (Howard et al. 2008). 
DNA nucleotide bases are methylated at three different positions. In bacteria and 
most eukaryotes, adenine can be modified at position N6 and cytosine can be 
methylated at the N4 position in thermophilic bacteria. In eukaryotes, the most 
commonly found modification of DNA is the methylation of the C5 position of 
cytosines (Jeltsch 2002). DNA methylation is carried out by DNA methyltransferases 
that all contain a set of conserved catalytic motifs (see below). 
Methylation of cytosines in the mammalian genome occurs primarily in the context of 
CpG dinucleotides. This dinucleotide is statistically underrepresented in the genome 
compared to other possible dinucleotides, a phenomenon termed CpG suppression 
(Robertson and Wolffe 2000). The reason for that is probably the hydrolytic 
deamination of methylcytosine, which creates a thymine in a TpG mismatch situation. 
The repair of this mismatch is much less efficient than the repair of the UpG 
mismatch that would result from the (much slower) deamination of unmethylated 
cytosine, because for uracil there exists a specialized repair mechanism (Shen et al. 
1994). This is due to the fact that uracil is not found in natural DNA. Thus, the DNA 
Introduction 
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methylation process probably led to the reduction of CpG dinucleotides during 
evolution.  
This reduction of the frequency of CpG dinucleotides can be observed especially in 
intergenic and intronic regions. On the other hand, repetitive sequences, like 
transposons and endogenous retroviruses, and CpG islands display less depletion of 
the CpG dinucleotide (Bird et al. 1985). CpG islands are found in the majority of 
human promoter regions and are often unmethylated in germ cells. This fact might 
have prevented these CpG dinucleotides from being lost during molecular evolution 
(see above). CpG islands can adopt tissue-specific methylation patterns without 
changes in the germ line cells (Lister et al. 2009), which leads to tissue-specific gene 
expression through differential promoter activity. Genes that are actively transcribed 
usually show hypomethylation at the transcription start site (TSS) and 
hypermethylation in the gene body (Laurent et al. 2010).  
DNA methylation is one possible mechanism for long-term silencing of genomic 
sequences (Robertson and Wolffe 2000), since repressive histone marks and 
chromatin structure can be altered dynamically upon environmental changes. DNA 
methylation is less dynamic and it is inherited through cell divisions and can prevent 
the reactivation of silent genes when it is present in the promoter regions, even when 
the repressive histone marks are reversed. In cancer cells, promoters of tumor 
suppressor genes are often also hypermethylated, which leads to repression of the 
respective gene (Jeltsch 2002). 
DNA methylation is especially important for the maintenance of genome integrity and 
the protection against potentially mobile DNA sequences (Howard et al. 2008). Since 
“selfish” genetic elements like transposons, retrotransposons and viruses are usually 
relatively enriched in CpG dinucleotides, they are heavily methylated (Yoder et al. 
1997b). This protects them from transcription and subsequent translocation. In some 
kinds of cancer cells, DNA is often hypomethylated, which might lead to the 
reactivation of transposable elements and to subsequent mutations.  
 
2.1.2 RNA methylation 
RNA molecules are modified much more extensively than DNA. More than 100 
different modifications (http://rna-mdb.cas.albany.edu/RNAmods/ (Rozenski et al. 
1999)) have been found in many types of cellular RNA, e.g. acetylation (Feldmann et 
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al. 1966; Johansson and Bystrom 2004) and methylation at various positions of 
different bases (Jackman et al. 2003; Kalhor and Clarke 2003), and some RNA 
species carry multiple modifications per molecule (Phizicky and Alfonzo 2010). These 
modifications stabilize the functional structure of RNAs and can even induce 
alternative folding under certain circumstances (Helm et al. 1999). 
Similar to DNA nucleotides, cytosines in RNA can also be methylated at position 5. 
This modification is found in many cellular RNAs and in all three living domains 
(Sprinzl and Vassilenko 2005). RNA m5C methyltransferases therefore are a large 
protein family that can be divided into several subfamilies (Motorin et al. 2009). The 
eukaryotic RNA m5C methyltransferases alone can already be divided into at least 4 
subfamilies: the Trm4 family, the Nop2/p120 family, the family of NSUN/NOP2/NOL2 
related proteins, and the unusual Dnmt2 family. 
The function of RNA methylation beyond the stabilization of 3D structures is not well 
established. An importance for the maintenance of proper translation has been 
suggested for methylation of tRNA molecules, and m5C in ribosomal RNA may 
participate in tRNA recognition (Wu et al. 1998; Vicens and Westhof 2001). Some 
evidence also points to an involvement of RNA methylation in the innate immune 
system, because methylated RNAs show a reduced activation of toll-like receptors, 
compared to their unmethylated counterparts (Kariko et al. 2005). There are also 
speculations about an involvement of RNA methylation in the regulation of epigenetic 
inheritance patterns (Rassoulzadegan et al. 2006). 
 
2.1.3 tRNA methylation 
Most of the known RNA modifications so far are found in tRNA molecules, which are 
among the most stable RNA molecules. tRNAs were the first small RNAs that were 
discovered, and their function in translation is well established. They fold into a 
characteristic secondary structure that is determined by the Watson-Crick base pairs 
in the sequence, and which is termed “cloverleaf” structure (Figure 1A). Furthermore, 
tRNAs form a L-shaped 3D structure through hydrogen bonds within the molecule. 
The tertiary structure can have multiple conformations, and base modifications 
contribute to the stabilization of a certain folding. 
Cellular tRNAs are also among the most strongly modified RNAs, and the 
modifications are predominantly found in the core of the L-shaped 3D structure as 
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well as in the anticodon loop. The core modifications are known to increase the 
thermal stability of tRNAs and lower the conformational flexibility (Helm 2006). 
Therefore, the core modifications are mostly “structural modifications”. In contrast, 
the modifications in the anticodon loop can also be “functional”. They contribute to 
codon recognition and frame shifting, with positions 34 and 37 being of special 
importance (reviewed in (Helm 2006)).  
            
Figure 1: tRNA structure and methylation sites 
(A) Secondary cloverleaf structure of tRNA. Circles represent single nucleotides. (B) Global 
distribution of methylation sites in different tRNAs. The frequency of m5C occurrence is color-coded: 
<10% = yellow, 10-30% = red, 30-60% = green, >60% = blue. Abbreviations: CY = cytoplasm, MI = 
mitochondria, ANI= animals, SIN = single cell eukaryotes, AR = archaea, BAC = bacteria, PLA = 
plants (modified after (Motorin et al. 2009)). 
 
Despite the high abundance of tRNA modifications, a number of these modifications 
were found to be non-essential, and the absence of these modifications often 
displays no or only weak phenotypes (Bjork 1995). Only a few modifications have a 
strong impact on tRNA structure, and it rather seems that many modifications 
contribute in a limited way to the stabilization of the structure (Alexandrov et al. 
2006). The combination of all the modifications improves the functionality and 
probably also the lifetime of tRNA molecules. 
A modification that can be studied more easily than many other modifications is the 
methylation at position 5 of cytosines (Helm 2006; Motorin et al. 2009). Although 
other bases can also be methylated, the cytosine methylation can be detected by 
bisulfite treatment and subsequent analysis of the methylation pattern after 
sequencing (Schaefer et al. 2009b). For many tRNAs, it was shown that m5C is 
clustered at the junction between the variable region and the TψC-stem, with 
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positions 48 and 49 being most frequently methylated (Figure 1B). Furthermore, 
positions in the anticodon loop were also identified as methylation sites (reviewed in 
(Motorin et al. 2009)). 
Methylation of cytosines in tRNA has a significance in structural stabilization, as was 
demonstrated for m5C at position 40 in tRNAPhe in S. cerevisiae. This modification is 
important for binding of Mg2+ ions and can induce conformational changes of the 
anticodon loop (Chen et al. 1993). Furthermore, cytosine methylation of tRNA can 
stabilize tRNA molecules and function to protect them from degradation via an 
exosome-independent pathway (RTD, rapid tRNA decay (Phizicky and Alfonzo 
2010)). This pathway degrades m5C-deficient tRNA in yeast, when cells are deleted 
for Trm4 (m5C) and Trm8 (m7G). Thus, the degradation is not dependent on the lack 
of m5C alone, but it is rather assumed that the lack of more than one modification 
leads to a destabilization of tRNA structure below a certain threshold, which 
subsequently leads to the degradation of destabilized tRNAs (Alexandrov et al. 
2006).  
Cytosine methylation is also important for the translation function of some tRNAs. 
This function is supported by the finding that the disruption of TRM4 leads to an 
increased sensitivity to the antibiotic paromomycin, which affects the precision of 
ribosome decoding. The m5C modification might therefore be involved in low error 
translation in yeast cells (Wu et al. 1998; Motorin et al. 2009). 
A recent study also provided evidence for the protection against stress-induced 
cleavage of tRNA molecules by cytosine methylation in the anticodon loop (Schaefer 
et al. 2010). Upon heat shock, tRNAs lacking m5C at position C38 were cleaved in 
D. melanogaster S2 cells. When m5C was present in these cells, the tRNA integrity 
was not affected (see below). 
2.1.4 The mechanism of cytosine methylation         
The methylation of cytosines in DNA and RNA requires distinct properties of the 
enzymes catalyzing the reaction, due to the differential nature of the two nucleic 
acids. However, the reaction mechanism of cytosine methylation is the same in both 
cases. The methylation of cytosines at position 5 of the aromatic ring is a chemically 
unusual reaction. Although the cofactor S-adenosyl-methionine (SAM) contains a 
highly reactive methyl group at the methionine sulfur atom and therefore is an 
effective methyl group donor, this reaction is not trivial. This is due to the fact that the 
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C5-position of cytosines is situated in an electron poor heterocyclic aromatic ring 
system, which reduces the reactivity of this carbon atom, compared to electron rich 
ring systems or non-aromatic compounds. Cytosine contains a carbonyl function and 
an amino function that have a negative inductive effect on the ring system. 
Accordingly, position 5 of this ring system is not able to perform a nucleophilic attack 
on the methyl group of the cofactor. 
To solve this problem, m5C methyltransferases developed a catalytic mechanism that 
activates the C5 position of the cytosine (Santi et al. 1984; Wu and Santi 1987). For 
this purpose, the enzyme has to gain access to both sides of the cytosine molecule. 
To this end, methyltransferases that modify the C5 position of pyrimidines developed 
a mechanism to flip the target base out of the nucleotide strand and embed it in the 
catalytic pocket of the enzyme (Klimasauskas et al. 1994; Reinisch et al. 1995). 
When the target base is located in the catalytic pocket, the reaction follows the 
pathway of a Michael addition (Figure 2). In a first step, a cysteine residue in the 
active centre provides a SH-group for a nucleophilic attack at position 6 of the target 
cytosine. This results in a covalent complex between the base and the enzyme as an 
intermediate. The nucleophilic attack is facilitated by transient protonation of the 
cytosine ring at the endocyclic nitrogen at position N3. This results in a highly 
reactive 4-5 enamin, which is an efficient nucleophile. Thus, the position C5 is 
activated and can attack the methyl group of the cofactor SAM. The methyl group is 
transferred to the base and the covalent base-enzyme complex is dissolved by 
deprotonation at position C5 by an unknown base within the enzyme and subsequent 
elimination of the SH-group from the initial cysteine (reviewed in (Jeltsch 2002)). 
 
 
Figure 2: Catalytic mechanism of m5C methyltransferases 
The reaction mechanism is based on the structure of the M.HhaI-DNA complex and was modified after 
the proposal of (Santi et al. 1984). The base within the enzyme, that abstracts the proton at C5 is 
unknown Enz=enzyme, Cys=cysteine, Ad=AdoMet, B=base(modified after (Jeltsch 2002)). 
 
RNA methyltransferases utilize different amino acid residues than DNA 
methyltransferases to catalyze the methylation of cytosines (Liu and Santi 2000). 
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They use a cysteine residue in motif VI (TCS peptide) to initiate the methylation 
reaction instead of the one in motif IV (PCQ) that is used by DNA methyltransferases. 
The cysteine in motif IV of RNA methyltransferases is not directly involved in the 
reaction (Figure 3). The transient protonation of the substrate that is performed by a 
glutamate residue in motif VI in DNA methyltranserases is carried out by an aspartate 
located in motif IV in RNA methyltransferases. Thus, the location of the two important 
catalytic residues is opposite to the location of those residues in DNA 
methyltransferases (Bujnicki et al. 2004). Only Dnmt2-type RNA methyltransferases 
methylate tRNA using a mechanism that is usually used by DNA methyltransferases 
(see below). 
      
Figure 3: Differences between RNA and DNA methyltransferases 
Canonical RNA m5C methyltransferases use the DAPC peptide in motif IV for protonation and the TCS 
peptide of motif VI for the initial nucleophilic attack on the C6 position. DNA m5C methyltransferases 
use an ENV peptide in motif VI for protonation and a PCQ peptide in motif IV for initiation. Dnmt2 
methylates a RNA substrate using the DNA methyltransferase mechanism (modified after (Schaefer 
and Lyko 2009)). 
 
2.2 DNA methyltransferases 
In eukaryotes, there are three distinct families of DNA methyltransferases (Dnmt1, 
Dnmt2 and Dnmt3). They all utilize specific amino acid residues from conserved 
motifs to catalyze the transfer of a methyl group from the cofactor SAM to the target 
DNA base, or in the case of Dnmt2 the target RNA base. 
In the ternary structure of DNA methyltransferases, the motifs I and X are folded 
together, so that they form the binding site for the cofactor SAM (Figure 4 (Cheng et 
al. 1993)). The catalytic cysteine that initiates the reaction is located in motif IV. This 
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motif is highly conserved and contains a PC-dipeptide in most of the known enzymes 
(Santi et al. 1984; Wu and Santi 1987). The glutamate residue that stabilizes the 
intermediate by transient protonation of the base is situated in motif VI (ENV 
tripeptide) of DNA methyltransferases. Another important amino acid residue is the 
arginine in motif VIII (Gowher et al. 2006). 
 
               
Figure 4: Topology of DNA methyltransferases 
Schematic drawing of the secondary structure of the prokaryotic methyltransferase M.HhaI. Boxes 
represent α-helices, arrows represent β-strands. The regularly dashed lines indicate hydrophobic 
interactions, the irregularly dashed lines indicate electrostatic interactions or hydrogen bonds. The 
methyltransferase motifs are colored: brown=motif I, orange=motif IV, red=motif VI, blue=motif VII, 
green=motif IX, yellow=motif X (modified from (Cheng et al. 1993)). 
 
DNA double strands can be found in three distinct states of methylation; they can be 
either unmethylated, hemimethylated, or they can be completely methylated on both 
strands. Therefore, two types of DNA methylation have to be distinguished (Riggs 
1975). One is de novo methylation that establishes methylation marks on 
unmethylated DNA (Okano et al. 1998a), and the second one is maintenance 
methylation that reestablishes methylation patterns after replication of methylated 
DNA (Bestor et al. 1988). In mammalian cells, two separate families of DNA 
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methyltransferases execute these distinct functions. Dnmt1 serves as a maintenance 
methyltransferase, because it has a preference for hemimethylated DNA (Pradhan et 
al. 1999), and Dnmt3 enzymes are responsible for de novo methylation, because 
they show no preference for hemimethylated over unmethylated DNA (Okano et al. 
1998a). However, despite the separation of the two functions of DNA methylation, the 
activities of the DNA methyltransferases responsible for each function partially 
overlap. Dnmt1 has a higher de novo methylation activity than Dnmt3a and 3b, and 
Dnmt3 family members have been implicated in maintenance methylation as well. 
 
2.2.1 The DNA nucleotide methyltransferase 1 (Dnmt1) 
The first eukaryotic DNA methyltransferase to be cloned and biochemically analyzed 
was murine Dnmt1 (DNA nucleotide methyltransferase 1 (Bestor et al. 1988)). In 
comparison to prokaryotic DNA methyltransferases, the protein is large, as it 
comprises 1620 amino acids and has an N-terminal regulatory domain. In initial 
studies, the de novo methyltransferase activity of Dnmt1 was identified (Bestor et al. 
1988), but later work discovered a pronounced preference for hemimethylated DNA 
(Yoder et al. 1997a; Fatemi et al. 2001). This property suggested that Dnmt1 was the 
methyltransferase responsible for the maintenance of methylation patterns. For this 
purpose, Dnmt1 is associated with the replication machinery through its interaction 
with PCNA (proliferating cell nuclear antigen), where it methylates the newly 
synthesized strand before the chromatin is reassembled. 
Disruption of Dnmt1 function results in global demethylation of genomic DNA. This 
leads to embryonic lethality in mice (Li et al. 1992), loss of imprinting (Li et al. 1993; 
Howell et al. 2001) and alterations in X chromosome inactivation (Beard et al. 1995; 
Panning and Jaenisch 1996; Sado et al. 2000). Embryonic stem cells without Dnmt1 
are viable, but unable to differentiate (Li et al. 1992). Other cell lines undergo 
apoptosis when Dnmt1 is missing (Jackson-Grusby et al. 2001; Takashima et al. 
2009). Taken together, these findings indicate an essential role for Dnmt1 in 
mammalian development, cell proliferation and survival. 
Dnmt1 contains all 10 catalytic motifs typical for m5C methyltransferases in the C-
terminal part of the enzyme. The large N-terminal domain is linked to the C-terminus 
by a lysine-glycine-rich domain and contains several functional domains (Figure 5). 
These domains include interaction domains with other proteins as well as nuclear 
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localization signals, BAH (bromo-adjacent homology) domains that are included in 
the PBHD (polybromo homology domain), and cysteine rich (CR) zinc-binding 
repeats that are involved in binding to unmethylated CpGs (Allen et al. 2006) and that 
are essential for the catalytic activity of Dnmt1 (Pradhan et al. 2008).  
          
Figure 5: DNA methyltransferase domains 
The domain architecture of mammalian DNA methyltransferases is shown. Functional domains of the 
regulatory N-terminal domains are coloured and labeled. The catalytic motifs in the C-terminal region 
are numbered. PBD=PCNA binding domain, NLS=nuclear localization signal, RFTD=replication foci 
targeting domain, CR=cysteine-rich domain, PBHD=polybromo homology domain, PWWP=proline-
tryptophan-tryptophan-proline, ADD= ATRX-DNMT3-DNMT3L (modified from (Jurkowska et al. 2011)). 
 
The enzyme is localized in the nucleus, where it is diffusely distributed when cells are 
not replicating during interphase. In S-phase, Dnmt1 is found at replication foci, 
where it methylates CpG dinucleotides, if the cytosine in the parental strand is 
methylated (Tatematsu et al. 2000). Interestingly, there is a slightly shorter oocyte-
specific isoform (Dnmt1o) that is located in the cytoplasm and only transiently found 
in the nucleus (Mertineit et al. 1998).  
The highly processive enzyme Dnmt1 is allosterically regulated by its own N-terminal 
domain. The catalytic C-terminal domain is not active without the N-terminus (Margot 
et al. 2000). When the N-terminus is bound to methylated DNA, the activity of Dnmt1 
on neighbouring cytosine target sites is increased, and its specificity shifts slightly 
from hemimethylated to unmethyated DNA (Fatemi et al. 2001; Goyal et al. 2006). 
When the N-terminus is bound to unmethylated DNA, the activity of the enzyme is 
inhibited (Bacolla et al. 1999; Flynn et al. 2003). This observation corresponds to the 
fact that methylation patterns in the human genome are bimodal, i.e. genomic 
regions are either highly methylated or not methylated at all. When the binding to 
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methylated DNA activates Dnmt1, then it is logical that during evolution methylated 
regions attract more methylation. On the other hand, poorly methylated regions 
would tend to loose methylation, when Dnmt1 is inhibited by unmethylated DNA 
(Jurkowska et al. 2011). The allosteric control of Dnmt1 activity by the N-terminal 
region would also provide an explanation for the fact that the isolated C-terminal 
domain is inactive, although it contains all the catalytic motifs. This mechanism would 
also prevent the genome from uncontrolled DNA methylation when Dnmt1 is 
fragmented by proteolysis. 
As a part of the epigenetic network, Dnmt1 interacts with a broad variety of proteins 
involved in epigenetic gene regulation. Among others HDAC1 (Fuks et al. 2000) and 
HDAC2 (Rountree et al. 2000), Dnmt3a and b (Kim et al. 2002), several transcription 
factors (Robertson et al. 2000), histone lysine methyltransferases and silencing 
effectors like HP1 and MeCP2 were shown to interact with Dnmt1 (Fuks et al. 2003; 
Kimura and Shiota 2003). Dnmt1 is associated to the replication machinery through 
its interaction with the processivity factor PCNA (Chuang et al. 1997). Another 
important interaction partner is UHRF1 (Bostick et al. 2007), which binds to 
hemimethylated DNA and thereby targets Dnmt1 to replicated DNA. Thus, UHRF1 is 
required for the maintenance of DNA methylation. 
It should also be noted that despite its maintenance function, Dnmt1 has a significant 
de novo methylation activity. This activity is even higher than the de novo methylation 
activity of Dnmt3. Furthermore, Dnmt1 probably plays a role in assisting Dnmt3 in de 
novo methylation by methylating hemimethylated DNA generated by Dnmt3 (Fatemi 
et al. 2001). 
 
2.2.2 The Dnmt3 family 
Due to the fact that Dnmt1 displays a preference for hemimethylated DNA and that in 
cells lacking Dnmt1 there is still some DNA methylation present, it was suggested 
that there exists at least one other DNA methyltransferase that carries out de novo 
methylation of unmethylated DNA double strands. This enzymatic activity was found 
when Dnmt3 methyltransferases were discovered (Okano et al. 1998a). This family of 
DNA methyltransferases comprises three members in mammals: Dnmt3a, Dnmt3b 
and Dnmt3L. Of these three, only Dnmt3a and Dnmt3b are active 
methyltransferases, and they display no preference for unmethylated or 
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hemimethylated DNA (Gowher and Jeltsch 2001). The amino acid sequence of 
Dnmt3L has several non-conservative mutations in the catalytic residues and it also 
lacks the catalytic motifs IX and X. 
Both Dnmt3a and 3b are divided into a catalytically active C-terminal domain and a 
regulatory N-terminal domain ((Xie et al. 1999), Figure 5). The N-terminal regions of 
the Dnmt3-familiy proteins are unrelated to the respective regions of Dnmt1. The C-
terminal region contains all 10 conserved motifs representing m5C-
methyltransferases and, in contrast to Dnmt1, the catalytical part is active in the 
absence of the N-terminus. Dnmt3a and Dnmt3b are also shown to methylate 
cytosines in a non-CpG context, but the biological significance of this methylation is 
unknown (Gowher and Jeltsch 2001). 
The N-terminal region of both enzymes contains a cysteine-rich domain (ADD 
(ATRX-DNMT3-DNMT3L) domain) and a PWWP (proline-tryptophan-tryptophan-
proline) domain. The ADD domain forms an interface for several interactions with 
other proteins. All Dnmt3 proteins have been shown to interact with the N-terminal 
tail of histone H3 through the ADD domain, but only when lysine 4 of histone H3 is 
unmodified (Ooi et al. 2007; Otani et al. 2009). The PWWP domain is essential for 
the targeting of Dnmt3a and 3b to pericentric chromatin, where they are involved in 
the methylation of different subsets of repeats. 
Dnmt3a and 3b are essential for embryonic development, and accordingly, the 
expression of both enzymes is high in embryonic tissues and undifferentiated 
embryonic stem (ES) cells and is down-regulated in differentiated cells (Okano et al. 
1998a). They both interact with the catalytically inactive Dnmt3L protein. 
Despite the numerous similarities of the Dnmt3 proteins, they also exhibit various 
differential properties; Dnmt3a-/- mice die shortly after birth, whereas the Dnmt3b 
knockout is lethal already at embryonic day 9.5 and causes multiple developmental 
defects (Okano et al. 1999). Dnmt3a interacts with the catalytically inactive Dnmt3L 
and is required for the establishment of imprints during gametogenesis. In contrast, 
Dnmt3b is not required for this process, but it methylates minor satellite repeats in 
embryos and ES cells, which does not require Dnmt3a. Furthermore, specific CpG 
islands on the inactive X chromosome seem to be methylated by Dnmt3b specifically, 
because inactivation of Dnmt3b in the human ICF (immunodeficiency-centromeric 
instability-facial anomalies) syndrome is the only human disease associated to a 
mutated DNA methyltransferase (Okano et al. 1999). Other results indicate a 
participation of Dnmt3b in maintenance DNA methylation. Taken together, these 
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results implicate only partially overlapping biological functions for Dnmt3a and 
Dnmt3b.   
Dnmt3L is the only Dnmt3 family member that is expressed specifically in germ cells 
during gametogensis and embryonic stages (Bourc'his and Bestor 2004). The 
localization of this protein depends on the distribution of the other Dnmt3s, because it 
is only found concentrated in chromatin foci, when Dnmt3a is present (Hata et al. 
2002) and it was shown to interact with both Dnmt3 methyltransferases (Margot et al. 
2003). The knockout of Dnmt3L results in viable mice with no morphological 
abnormalities. However, male knockouts are sterile, and female mutants are unable 
to deliver viable offspring. Loss of Dnmt3L leads to a loss of maternal imprints, which 
leads to biallelic expression of genes normally transcribed from the paternal allele 
(Hata et al. 2002).  
 
2.2.3 The unusual Dnmt2 enzymes 
All organisms that contain members of the Dnmt1 and Dnmt3 families, additionally 
contain a member of the Dnmt2 family of methyltransferases (Goll and Bestor 2005). 
On the other hand, organisms that contain a Dnmt2 homolog do not necessarily have 
Dnmt1 or Dnmt3 proteins. There are several species that contain a Dnmt2 homolog 
as the sole m5C-methyltransferase, e.g. Drosophila melanogaster, Dictyostelium 
discoideum, Entamoeba histolytica and Schizosaccharomyces pombe. Therefore, 
enzymes belonging to the Dnmt2 family are the most widely distributed enzymes of 
the eukaryotic DNA methyltransferases (Schaefer and Lyko 2009).  
Dnmt2 was identified by an EST (expressed sequence tag) database search as a 
new candidate DNA methyltransferase (Yoder and Bestor 1998). Sequence 
homology revealed that Dnmt2 is related to the putative DNA methyltransferase that 
was annotated in the fission yeast genome (Wilkinson et al. 1995). In search for an 
explanation for the residual DNA methylation in Dnmt1 null mutant mouse embryonic 
stem cells, Dnmt2 was found to belong to the DNA methyltransferase family, 
because it contains all 10 conserved motifs that are characteristic for DNA 
methyltransferases in the canonical order. Although it lacks the large N-terminal 
domains that are present in Dnmt1 and Dnmt3, the catalytic domain is well 
conserved. The assumption that Dnmt2 belonged to the DNA methyltransferase 
family was further supported by the observation that the crystal structure of Dnmt2 is 
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essentially superimposable with the structure of the bacterial restriction 
methyltransferase M.HhaI (Figure 6). This indicated that the calatytic motifs of Dnmt2 
are well organized and in the correct orientation for a DNA methyltransferase (Dong 
et al. 2001). However, no DNA methyltransferase activity could be detected in initial 
studies of mammalian Dnmt2 homologs, although denaturant resistant binding to 
DNA has been observed for Dnmt2 in vitro (Okano et al. 1998b; Dong et al. 2001). 
Other laboratories were able to detect Dnmt2 dependent DNA methylation, but the 
level was very low and close to the backgound of the assays applied (Hermann et al. 
2003; Tang et al. 2003). Recombinant human Dnmt2 was shown to methylate a low 
amount of cytosines in DNA substrates in a nonprocessive manner and without 
sequence specificity (Hermann et al. 2003). DNA bisulfite sequencing suggested 
methylation of isolated cytosines in Drosophila DNA that was also not sequence 
specific (Lyko et al. 2000). Thus, the DNA methylation activity under the conditions 
that were examined was residual. More recently, a specific methylation activity on 
certain retroelements has been observed. Locus specific methyltransferase activity 
on selected retroelements in the genomes of Drosophila and Dictyostelium has been 
reported by independent groups (Kuhlmann et al. 2005; Phalke et al. 2009), but 
these results are controversially discussed (Schaefer and Lyko 2010) and need 
further investigation. 
Sequence comparisons show that the target recognition domain (CFTXXYXXY) is 
highly conserved among Dnmt2 family members, but that this motif is not found in 
other DNA methyltransferases. When DNA is modeled into the crystal structure of 
Dnmt2, the second tyrosine (Y) of the CFT motif is in significant steric conflict with 
the non-target strand of double stranded DNA (Goll and Bestor 2005).  
When purified human Dnmt2 was used for in vitro methylation of DNA and RNA 
extracts from Dnmt2-/- mouse tissues, a small RNA was detected that could be 
methylated by Dnmt2 that was not methylated in extracts from wild type tissues (Goll 
et al. 2006). This small RNA was identified as tRNAAsp, and the methylation was 
localized specifically to the cytosine base at position 38 in the anticodon loop of the 
tRNA. This tRNA can also be methylated, if the substrate is an in vitro transcribed 
RNA that lacks any other modification (Hengesbach et al. 2008; Jurkowski et al. 
2008). 
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Figure 6: Structure of Dnmt2 
(A) Ribbon diagram of the Dnmt2∆47-AdoHcy complex in the front view. (B) Ribbon diagram of the 
Dnmt2∆47-AdoHcy complex in the right side view. Helices and loops in (A) and (B) are coloured red, 
unique helices of Dnmt2 are coloured gray, strands are green the PC loop is light blue and the TRD 
loop is green. AdoHcy and the CFT of the TRD are shown as balls with carbon atoms in black, 
nitrogen in light blue, oxygen in magenta and sulfur atoms in orange. (C) Superimposition of the 
Dnmt2∆47 in yellow and blue and M.HhaI in green (Dong et al. 2001). 
 
When purified human Dnmt2 was used for in vitro methylation of DNA and RNA 
extracts from Dnmt2-/- mouse tissues, a small RNA was detected that could be 
methylated by Dnmt2 that was not methylated in extracts from wild type tissues (Goll 
et al. 2006). This small RNA was identified as tRNAAsp, and the methylation was 
localized specifically to the cytosine base at position 38 in the anticodon loop of the 
tRNA. This tRNA can also be methylated, if the substrate is an in vitro transcribed 
RNA that lacks any other modification (Hengesbach et al. 2008; Jurkowski et al. 
2008). 
Thus, Dnmt2 is an unusual enzyme. Sequence and homology data imply a DNA 
methyltransferase activity, but experimental data suggest that the tRNA 
methyltransferase activity of Dnmt2 is much more robust than any detectable activity 
on DNA. On the other hand, Dnmt2 does not share significant sequence similarities 
with typical RNA methyltransferases. The unique position of Dnmt2 as a tRNA 
methyltransferase became even more pronounced when it was shown that Dnmt2 
uses a DNA methyltransfease-like mechanism to methylate tRNA (Jurkowski et al. 
2008). Typical RNA methyltransferases use a peptide in motif IV for protonation of 
the substrate and a peptide in motiv VI for catalysis, whereas the role of the two 
different motifs is reversed in DNA methyltransferases. Dnmt2 uses the motifs like 
DNA methyltransferases do, but the substrate is RNA.  
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The subcellular localization of the enzyme varies significantly. It was found in the 
nucleus (Kunert et al. 2003; Kuhlmann et al. 2005), in the cytoplasm (Goll et al. 2006; 
Rai et al. 2007) or both (Schaefer et al. 2008) and also associated to the nuclear 
matrix (Banerjee et al. 2005; Schaefer et al. 2008). The nuclear localization is in 
agreement with both the DNA and the tRNA methyltransferase activity, whereas a 
cytoplasmic localization would rather point towards the tRNA methyltransferase 
activity. 
Despite the knowledge about the localization of the protein and the targets of 
methylation, it has been difficult to determine the biological function of Dnmt2 or the 
tRNA methylation at position C38. Although Dnmt2 is highly conserved through 
evolution, which indicates an important cellular function, mutant organisms mostly 
show no or only very subtle phenotypes under standard laboratory conditions. 
S. pombe, D. melanogaster, A. thaliana and mouse mutants were indistinguishable 
from wild-type (Wilkinson et al. 1995; Kunert et al. 2003; Goll et al. 2006) and 
D. discoideum showed a minor developmental phenotype (Katoh et al. 2006). 
Surprisingly, zebrafish displayed lethal defects in the differentiation of retina, liver and 
brain when Dnmt2 was knocked down (Rai et al. 2007).  
More detailed analysis of Dnmt2 mutants in different “Dnmt2-only” organisms implied 
several interesting possibilities for biological function. The overexpression of the 
Drosophila homolog was found to cause increased resistance to various stresses like 
starvation or oxidative stress and furthermore to increase the mean lifespan of the 
flies (Lin et al. 2005). These observations were supported by a second study that 
was able to reproduce the aging phenotype and the resistance to oxidative stress 
(Schaefer et al. 2010). This study furthermore identified additional methylation targets 
of Drosophila Dnmt2, tRNAGly and tRNAVal, and discovered the protection of 
methylated tRNAs against stress induced cleavage. Other studies on this Dnmt2 
homolog concentrated on the DNA methylation activity and reported methylation of 
retrotransposons that was detected using DNA bisulfite sequencing (Phalke et al. 
2009). However, these findings were questioned and require further investigation 
(Schaefer and Lyko 2010; Krauss and Reuter 2011). 
The Dictyostelium homolog (DnmA) has been shown to be responsible for the small 
amount of DNA methylation found in the D. discoideum genome (Kuhlmann et al. 
2005). This organism also exhibits morphological defects in late development that 
were attributed to the DNA methylation activity of DnmA that occurs at specific 
retrotransposons (Katoh et al. 2006). However, later studies have also identified 
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robust tRNAAsp methyltransferase activity for DnmA, equivalent to the activity of the 
other known Dnmt2 homologs (Sara Müller, Wolfgang Nellen, unpublished data). 
Additionally to the tRNAAsp methylation, DnmA was able to methylate tRNAGlu of 
Dictyostelium. 
Another “Dnmt2-only” organism like Drosophila and Dictyostelium is the protozoan 
parasite Entamoeba histolytica. The Dnmt2 homolog in this organism is named 
Ehmeth and was shown to exhibit a weak DNA methyltransferase activity when 
genomic DNA was used as a substrate. Additionally, the amoeba showed impaired 
ability to kill mammalian cells when the activity of Dnmt2 was inhibited by 5-
azacytidine (Fisher et al. 2004). Surprisingly, Ehmeth was shown to interact with the 
glycolytic enzyme enolase, which causes inhibition of Ehmeth tRNAAsp methylation 
activity. The inhibition of Ehmeth by enolase could be influenced by the enolase 
substrate (Tovy et al. 2010a). These findings suggest regulation of Ehmeth by 
enolase outside of its glycolytic function.  
Studies on the substrate recognition of the human Dnmt2 enzyme suggest that a 
tRNA is a “good” substrate, if it contains a cytosine at position 38 and additionally 
carries a cytosine at position 32, an adenine at position 37 and another cytosine at 
position 40. These bases are present in the tRNAAsp sequences of H. sapiens, 
S. pombe, D. discoideum and probably most of the other Dnmt2 containing 
organisms. The respective bases that are present in the S. cerevisiae tRNAAsp (U32, 
G37, U40) are antideterminants and are probably the reason why the S. cerevisiae 
tRNAAsp is not a substrate for methylation by Dnmt2, although it contains a cytosine 
at position C38 (M. Helm, personal communication). 
 
2.3 The fission yeast Schizosaccharomyces pombe as a model 
organism 
The fission yeast Schizosaccharomyces pombe is a unicellular eukaryotic organism. 
It was isolated from east-african millet beer and named “pombe” after the Swahili 
word for beer (Lindner 1893). It was established as a model organism in the 1950s 
(Leupold 1950) and has been used for genetic studies as well as cell cycle research.  
S. pombe’s rod-shaped cells are usually 3-4 µm in diameter and 7-14 µm in length. In 
contrast to the baker’s yeast Saccharomyces cerevisiae, fission yeast grows 
exclusively at the tips and divides by medial fission instead of budding. Under normal 
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conditions, the cells are haploid, and diploids are obtained only under starvation 
conditions. The 13.8 Mbp genome of the fission yeast was completely sequenced 
(Wood et al. 2002), and it contains about 5000 ORFs distributed on three 
chromosomes. The localization of all proteins was determined using GFP-tagged 
proteins (Matsuyama et al. 2006). 
Despite its small genome, the fission yeast displays significant similarities to higher 
eukaryotes like the centromere structure, the presence of introns in gene sequences 
and the utilization of an RNA interference system. Furthermore, cell cycle and cellular 
structure are comparable to higher eukaryotes. In contrast to higher eukaryotes, 
however, S. pombe has the advantages of simple cultivation, short replication time 
and easy accessibility of the genome for mutations. The fact that this organism is well 
investigated and that methods for genetic manipulation are well established provides 
versatile possibilities for research on genetics and protein function. 
Fission yeast was chosen for this study, because it contains an annotated putative 
DNA methyltransferase that belongs to the Dnmt2 family of DNA methyltransferases. 
Besides this protein, there are no other putative DNA methyltransferases annotated 
in the S. pombe genome. Therefore, the fission yeast is a “Dnmt2-only” organism. 
This fact makes it an ideal organism to study the function of a Dnmt2 homolog. The 
absence of other DNA methyltransferases obviates the necessity of excluding the 
possibly overlapping DNA methyltransferase activity of similar enzymes when 
studying Dnmt2 activity. 
 
2.4 The pombe methyltransferase 1 (Pmt1) 
The fission yeast Schizosaccharomyces pombe contains a single gene encoding for 
a putative DNA methyltransferase. The pombe methyltransferase 1 (Pmt1) was 
identified based on its sequence homology to bacterial m5C methyltransferases 
(Wilkinson et al. 1995). It contains all 10 conserved motifs that are characteristic for 
m5C methyltransferases in the correct order. In contrast to the previously known 
eukaryotic m5C methyltransferases (Dnmt1 family), it lacks the large N-terminal 
domain and was therefore more similar to the prokaryotic methyltransferases than to 
Dnmt1. After the identification of mammalian Dnmt2, it was recognized that Pmt1 
shared high similarity with this eukaryotic DNA methyltransferase family and thus 
was the first Dnmt2 homolog to be identified (Yoder and Bestor 1998).  
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Already in the first study on Pmt1, it was observed that the protein sequence deviates 
from the consensus sequence of DNA methyltransferases in the catalytic motif IV. 
Other m5C methyltransferases contain the peptide PPCQ, which includes the 
catalytic cysteine that initiates the methyl group transfer (Figure 7). In Pmt1, this 
sequence is altered to PSCQ. Recombinant Pmt1 was able to bind to specific DNA 
sequences, but was not able to methylate DNA substrates, which was attributed to 
the mutation in the catalytic motif IV, and which was consistent with the lack of 
detectable DNA methylation in the fission yeast (Antequera et al. 1984). One further 
study reported an activation of the pmt1+ gene product by deletion of the serine 
residue in the PSCQ motif IV (Pinarbasi et al. 1996). This deletion “reestablishes” a 
PCQ tripeptide in the catalytic motif IV that is also found in other DNA 
methyltransferases like Dnmt1. Wild type and mutant protein were able to bind to 
specific DNA fragments at a CCAGG sequence, but only the mutant protein 
displayed specific DNA methyltransferase activity. These results suggest a sequence 
specificity for the mutant protein that is equivalent to the restriction methyltransferase 
M.EcoRII and are discussed controversially. 
Initial studies provided evidence that the pmt1+ gene is transcribed at a significant 
level. However, the deletion of the pmt1+ gene resulted in cells that were 
indistinguishable from wild type cells (Wilkinson et al. 1995). Therefore, pmt1+ is not 
essential for vegetative growth, conjugation or meiosis of the fission yeast. It was 
also mentioned that the function of the pmt1+ gene might only be required under 
certain conditions, because strains grown in a laboratory are not a subject to the 
same environmental stresses as cells that inhabit their natural environment. 
Furthermore, the presence of the proline to serine mutation next to the catalytic 
cysteine can be found in certain tRNA methyltransferases, which could indicate that a 
proline to serine mutation does not automatically render the enzyme inactive and 
may suggest a tRNA methyltransferase activity for Pmt1 (Wilkinson et al. 1995). 
Especially due to the findings on activity of the human homolog Dnmt2 (Goll et al. 
2006), a tRNA methyltransferase activity can be postulated for Pmt1 in S. pombe. 
Despite this notion, the tRNA methyltransferase activity of Pmt1 to date has not been 
investigated. 
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Figure 7: Multiple sequence alignment of Dnmt2 proteins 
Alignment of the amino acid sequences of the Dnmt2 homologs from S. pombe, D. melanogaster, 
H. sapiens, M. musculus, D. discoideum and E. histolytica using the ClustalW2 algorithm. The 
mutation motif IV of Pmt1 is marked with a box. Catalytic motifs and the target recognition domain are 
labeled with black bars. 
 
S.pombe_Pmt1              MLSTKRLRVLELYSGIGGMHYALNLANIPA-DIVCAIDINPQANEIYNLNHG-KLAKHMD 58
D.melanogaster_Dnmt2      ----MPLIVSSSIMIHAKLIYTFEDAQLDG-QIVAALDVNTVANAVYAHNYGSNLVKTRN 55
human_Dnmt2               ---MEPLRVLELYSGVGGMHHALRESCIPA-QVVAAIDVNTVANEVYKYNFPHTQLLAKT 56
M.musculus_Dnmt2          ---MEPLRVLELYSGIGGMHHALRESHIPA-HVVAAIDVNTVANEVYKHNFPHTHLLSKT 56
D.discoideum_DnmA         ---MEQLRVLEFYSGIGGMHYGLQESGVDF-QVIQSFDINTNANLNYKYTFN-EDSSQKS 55
E.histolytica_Ehmeth      -MQQKQVNVIEFFSGIGGLRSSYERSSININATFIPFDINEIANKIYSKNFK-EEVQVKN 58
                                       
S.pombe_Pmt1              ISTLTAKDFDAFDCKLWTMSPSCQPFTR--IGNRKDILDPRSQAFLNIL-NVLPHVNNLP 115
D.melanogaster_Dnmt2      IQSLSVKEVTKLQANMLLMSPPCQPHTR--QGLQRDTEDKRSDALTHLC-GLIPECQEL- 111
human_Dnmt2               IEGITLEEFDRLSFDMILMSPPCQPFTR--IGRQGDMTDSRTNSFLHIL-DILPRLQKLP 113
M.musculus_Dnmt2          IEGISLEDFDKLSFNMILMSPPCQPFTR--IGLQGDMTDPRTTSFLYIL-DILPRLQKLP 113
D.discoideum_DnmA         IESYSVEELEGFKANAWLMSPPCQPFTR--LGLQKDDQDNRTNSFFHLL-DVLTKIKDPP 112
E.histolytica_Ehmeth      LDSISIKQIESLNCNTWFMSPPCQPYNNSIMSKHKDINDPRAKSVLHLYRDILPYLINKP 118
                          
S.pombe_Pmt1              EYILIENVQGFE---ESKAAEECRKVLRNCGYNLIEGILSPNQFNIPNSRSRWYGLARLN 172
D.melanogaster_Dnmt2      EYILMENVKGFE---SSQARNQFIESLERSGFHWREFILTPTQFNVPNTRYRYYCIARKG 168
human_Dnmt2               KYILLENVKGFE---VSSTRDLLIQTIENCGFQYQEFLLSPTSLGIPNSRLRYFLIAKLQ 170
M.musculus_Dnmt2          KYILLENVKGFE---VSSTRGLLIQTIEACGFQYQEFLLSPSSLGIPNSRLRYSLIAKLQ 170
D.discoideum_DnmA         TYILIENVFGFAKKGSSNTRDHLLDTLIKMNYSFQEFHLSPQQFGLANQRLRYFCIAKRN 172
E.histolytica_Ehmeth      KHIFIENVPLFK---ESLVFKEIYNILIKNQYYIKDIICSPIDIGIPNSRTRYYVMARLT 175
                             
S.pombe_Pmt1              FK-GEWSID--------------------------------------------------- 180
D.melanogaster_Dnmt2      AD-FPFAGG--------------------------------------------------- 176
human_Dnmt2               SEPLPFQAPGQVLMEFPKIESVHPQKYAMDVENKIQEKNVEPNISFDG-SIQCSGKDAIL 229
M.musculus_Dnmt2          SEPFPFQAPGQILMEFPKIVTVEPQKYAVVEESQPRVQRTGPRICAESSSTQSSGKDTIL 230
D.discoideum_DnmA         GK-LNFKKEQDKHNEKVDENKLNNNSNNNNEQNKYDN----------------------- 208
E.histolytica_Ehmeth      PF---------------------------------------------------------- 177
                                                                                      
S.pombe_Pmt1              ---DVFQFS--EVAQKEGE-VKRIRDYLEIER----DWSSYMVLESVLNKWGHQFDIVKP 230
D.melanogaster_Dnmt2      ---KIWEEMPGAIAQNQG--LSQIAEIVEEN-----VSPDFLVPDDVLTKRVLVMDIIHP 226
human_Dnmt2               FKLETAEEIHRKNQQDSDLSVKMLKDFLEDDT----DVNQYLLPPKSLLRYALLLDIVQP 285
M.musculus_Dnmt2          FKLETVEERDRKHQQDSDLSVQMLKDFLEDG-----DTDEYLLPPKLLLRYALLLDIVKP 285
D.discoideum_DnmA         --LKILDHIPGYDFHTTLEECDEISNYFDKDLTDDELYEKYKVPHNLLLSKGMLFDIKQK 266
E.histolytica_Ehmeth      ----------KNEIQLHQEKESMISNYLDNN-----VNESYSIPSDLILKKGMLFDIVGK 222
                                     
S.pombe_Pmt1              DSSSCCCFTRGYTHLVQGAGSILQMSDHENTHEQFE-------RNR-------------- 269
D.melanogaster_Dnmt2      AQSRSMCFTKGYTHYTEGTGSAYTPLSEDESHRIFELVKEIDTSNQDASKSEKILQQRLD 286
human_Dnmt2               TCRRSVCFTKGYGSYIEGTGSVLQTAEDVQVENIYKSLTNLSQEEQ------------IT 333
M.musculus_Dnmt2          TSRRSMCFTKGYGSYIEGTGSVLQAAEDAQIENIYKSLPDLPPEEK------------IA 333
D.discoideum_DnmA         DSKTSNCVTKSYGKFIEGTGSIIQMDNN-FKADIND--------NK-------------- 303
E.histolytica_Ehmeth      DDKRTCCFTKSYTKIVEGTGSIYCPIEPHFIPVKKA-----------------------E 259
                                                                 
S.pombe_Pmt1              --MALQLRYFTAREVARLMGFPESLEWSKSNVTEKCMYRLLGNSINVKVVSYLISLLLEP 327
D.melanogaster_Dnmt2      LLHQVRLRYFTPREVARLMSFPENFEFP-PETTNRQKYRLLGNSINVKVVGELIKLLTIK 345
human_Dnmt2               KLLILKLRYFTPKEIANLLGFPPEFGFP-EKITVKQRYRLLGNSLNVHVVAKLIKILYE- 391
M.musculus_Dnmt2          KLSMLKLRYFTPKEIANLQGFPPEFGFP-EKTTVKQRYRLLGNSLNVHVVAKLLTVLCEG 392
D.discoideum_DnmA         SLIPLKLRYFSPKEITRLHGFPEEFKFS-PKLTTIQCYRLIGNSLNVKIVSELLKVLVSP 362
E.histolytica_Ehmeth      DLLNKNLRYFTPNEIKKIHGFSSNFTTQIDGLTDKQQYQCLGNSVSCFVIAQLMEYLFDD 319
                              
S.pombe_Pmt1              LNF-------------------- 330
D.melanogaster_Dnmt2      -----------------------
human_Dnmt2               -----------------------
M.musculus_Dnmt2          FGNASESCHKMPLILDSNSKILS 415
D.discoideum_DnmA         NEEEEQQEQQKEKEGKK------ 379
E.histolytica_Ehmeth      LKE-------------------- 322
                                                 
motif I motif II
motif III motif IV
motif VI motif VIII
TRD
motif IX motif X
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3 Aim of this thesis 
The identification of the tRNA methyltransferase activity of the DNA 
methyltransferase homolog Dnmt2 has highlighted the exceptional role of this 
enzyme among the eukaryotic DNA methyltransferases. The strong conservation of 
Dnmt2 proteins, along with the existence of Dnmt2-only organisms, suggests an 
important biological function of Dnmt2 activity. However, the nature of this function is 
only poorly understood. Therefore, Dnmt2 enzymes and the biological role of this 
tRNA methyltransferase activity has raised increasing interest in the scientific 
community. 
The fission yeast Schizosaccharomyces pombe provides favorable circumstances to 
investigate the function of a Dnmt2 homolog, because it contains such a homolog, 
but lacks any additional DNA methyltransferases. Therefore, we chose to investigate 
the function and biological role of the fission yeast Dnmt2 homolog Pmt1. This 
homolog has not been investigated for its tRNA methyltransferase activity and was 
claimed to be inactivated by a mutation in its catalytic motif IV. Insights into Pmt1 
function could lead to a better understanding of the mammalian homolog that has 
already been implicated as a possible biomarker for monitoring azacytidine treatment 
of cancer patients (Schaefer et al. 2009a). Research in other organisms indicated an 
involvement of Dnmt2 function in aging (Lin et al. 2005; Schaefer et al. 2010), 
development (Rai et al. 2007) and stress resistance (Schaefer et al. 2010), all of 
which are important research fields associated with human diseases. 
In the course of this study, we sought to determine whether Pmt1 is an active tRNA 
methyltransferase both in vitro and in vivo. Our observations concerning Pmt1-
dependent in vivo methylation prompted us to investigate the influence of nutrient 
availability on the activity of the fission yeast Dnmt2 homolog and led to the discovery 
of an unexpected link between Pmt1-dependent tRNA methylation and cellular 
signaling pathway involving the serine/threonine kinase Sck2. Based on results from 
other Dnmt2 homologs, we furthermore sought to identify the role of Pmt1 in the 
process of chronological aging.  
In summary, the aim of this study was the unbiased characterization of Pmt1 activity, 
based on previous results on Pmt1 (no detectable DNA methyltransferase activity) 
and Dnmt2 (tRNAAsp methyltransferase activity) using genetic as well as biochemical 
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approaches. In the course of this study we were able to identify an activity for Pmt1 
that was specific for cytosine 38 of tRNAAsp. The S. pombe tRNAGlu was an additional 
target of Pmt1 methylation. Surprisingly, we discovered a nutrient dependency of 
Pmt1 activity in vivo and were able to determine a factor that regulates Pmt1 activity. 
The involvement of the serine/threonine kinase Sck2 in Pmt1 regulation suggested 
that tRNA methylation might be regulated by nutrient availability via the TOR 
signaling pathway. Additional results implied a role for Pmt1 activity in chronological 
aging.  
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4 Materials and methods 
4.1 E. coli strains 
Rosetta (DE3)    F- ompT hsdSB(rB- mB-) gal dcm pRARE (CamR) (Merck) 
TOP10  F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araΔ139Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
(Invitrogen) 
DH5α  F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, 
mk+) phoA supE44 thi-1 gyrA96 relA1 λ- (Invitrogen) 
 
4.2 Media and growth conditions 
All E. coli strains used for plasmid purification were cultured at 37 °C in Luria-Bertani 
(LB) medium containing 100 µg/mL ampicillin according to standard procedures 
(Sambrook et al. 1989). 
S. pombe strains were cultured according to standard protocols (Moreno et al. 1991). 
Media that were used in this study are given in Table 1. If not stated otherwise, yeast 
cells were grown in standard complete medium (YES) or in minimal medium (EMM) 
with 2 % glucose and the required supplements at 30 °C. For selection for antibiotic 
resistance, YES medium was supplemented with 100 mg/L G418 (Gerbu), 100 mg/L 
cycloheximide (Carl Roth) or 100 mg/L nourseothricin (ClonNat, Werner Bioagents). 
S. cerevisiae standard complete medium (YPD) and standard minimal medium (YM) 
supplemented with 2% glucose and the required supplements was also used for S. 
pombe cultures in this study. Solid media were prepared by addition of 2 % agar. 
 
Table 1: Media used in this study 
Medium Composition 
YES 
5 g/L yeast extract 
30 g/L glucose 
250 mg/L adenine 
250 mg/L histidine 
250 mg/L leucine 
250 mg/L uracil 
Material and methods 
 33 
250 mg/L lysine 
EMM 
3 g/L potassium hydrogenphtallate 
2.2 g/L Na2HPO4 
5 g/L NH4Cl  
20 g/L glucose 
20 mL/L 50x salt stock  
1 mL/L 1000x vitamine stock  
100 µL/L 10000x mineral stock 
YPD 
10 g/L yeast extract 
20 g/L peptone 
20 g/L glucose 
SPAS 
10 g/L glucose 
1 g/L KH2PO4 
1 mL/L 1000x vitamine stock 
45 mg/L adenine 
45 mg/L histidine 
45 mg/L leucine 
45 mg/L uracil 
45 mg/L lysine 
YM 6.7 g/L yeast nitrogen base w/o amino acids 
 
Stock solutions for S. pombe media were prepared according to standard protocols 
(Moreno et al. 1991), filter sterilized and stored at 4 °C. The composition of these 
solutions is given in Table 2. 
 
Table 2: Stock solutions for S. pombe media 
Stock solution composition 
50x salt stock 
52.5 g/L MgCl2*6 H2O  
0.735 g/L CaCl2*2 H2O 
50 g/L KCl 
2 g/L Na2SO4 
1000x vitamine stock 
1 g/L pantothenic acid 
10 g/L nicotinic acid 
10 g/L inositol 
10 mg/L biotin 
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10000x mineral stock 
5 g/L boric acid 
4 g/L MnSO4 
4 g/L ZnSO4*7 H2O 
2 g/L FeCl2*6 H2O 
0.4 g/L molybdic acid 
1 g/L KI 
0.4 g/L CuSO4*5 H2O 
10 g/L citric acid 
 
4.3 Schizosaccharomyces pombe strains  
S. pombe strains used in this study are given in Table 3. The strains originated from 
the laboratory collection or from a deletion library that contained deletions of nearly 
all non-essential genes (Bioneer). Additional deletions were obtained by direct 
deletion of the respective gene using genomic integration of either a kanMX or a 
natMX cassette (Janke et al. 2004). Additional strains were kindly provided by the 
indicated sources. 
 
Table 3: S. pombe used in this study 
Name Genotype Source 
AEP1 h- leu1-32 ura4-D18 his3-D3 YGRC 
AEP8 h- leu1-32 ura4-D18 his3-D3 pmt1∆::kanMX this study 
AEP10 h- leu1-32 ura4-D18 his3-D3 pmt1-TAP/kanMX this study 
AEP11 h- leu1-32 ura4-D18 his3-D3 pmt1-GFP/kanMX this study 
AEP37 h
- leu1-32 ade6-210 ura4-D18 mat1_m-cyhS smt0 
rpl42::cyhR(sP56Q) pmt1∆::natMX this study 
AEP57 h+ leu2-32 ura4-D18 ade6-210 Bioneer  
AEP61 h- leu2-32 ura4-D18 his7-366 ade6-216 sck1∆::LEU2 Kurt Runge 
AEP62 h- leu2-32 ura4-D18 his7-366 ade6-216 sck2∆::LEU2 Kurt Runge 
AEP117 h+ leu2-32 ura4-D18 ade6-216 pka1∆::kanMX Bioneer 
AEP119 h+ leu2-32 ura4-D18 ade6-216 sck2∆::kanMX Bioneer 
AEP120 h+ leu2-32 ura4-D18 ade6-216 tor1∆::kanMX Bioneer 
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AEP125 h
+ leu2-32 ura4-D18 ade6-216 pka1∆::kanMX 
pmt1∆::natMX this study 
AEP126 h
+ leu1-32 ura4-D18 ade6-216 sck2∆::kanMX 
pmt1∆::natMX this study 
 
4.4 Molecular cloning 
Plasmids used in this study originated from or were derived from the laboratory 
collection (Table 4). Plasmids were generated according to standard cloning 
techniques (Sambrook et al. 1989). Kits for plasmid isolation and gel purification of 
PCR fragments were purchased from Qiagen. Restriction enzymes and the 
respective buffers were used from NEB. 
For the exchange of single amino acids, the PCR sewing technique was used. With 
this method in a first step short complementary overhangs were created that contain 
the desired mutation. These PCR products served as polymerase start sites in a 
second PCR reaction. The intron-less sequence of pmt1+ was generated by reverse 
transcription of S. pombe RNA with randon hexamers. PCR using the cDNA as 
template and pmt1-specific primers with overhangs containing XhoI and BamHI 
restriction sites amplified intron-less pmt1-fragments that were cloned into the 
pET15b vector. The resulting pET15b-pmt1 plasmid (pAE1372) served as a template 
for the generation of other pmt1-containing vectors (pAE1462, pAE1590, pAE1666, 
pAE1890, pAE1891). For the replacement of the nmt1 promoter by the pmt1 
promoter in pAE1891, the nmt1 sequence was excised from pAE1890 using XhoI 
and PstI restriction sites. The pmt1 promoter that was generated from the 400 bp 
upstream of the genomic pmt1 locus by PCR was inserted into the vector using the 
same restriction sites. The Dnmt2 expression vector pAE1385 was a kind gift from 
A. Jeltsch (Jurkowski et al. 2008). The in vitro transcription vectors were generated 
as described below. 
 
Table 4: Plasmids used in this study 
Name Vector Description 
pAE1372 pET15b-pmt1 XhoI-pmt1-BamHI (intron-less pmt1
+-
sequence) 
pAE1385 pET28a(+)-hDnmt2 HindIII-hDnmt2-XhoI (T. Jurkowski) 
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pAE1429 REP4X nmt1-promoter, ars1, ura4+ marker 
pAE1434 pSLF172 Designed to tag expressed protein at C-terminus with 3xHA-tag, nmt1-promoter 
pAE1445 pSGP572a nmt1-promoter, ars1, ura4+ marker, NotI-TTG-GFP-TAG-SalI 
pAE1462 REP4X-pmt1 BamHI-pmt1-SmaI (intron-less pmt1
+-
sequence) 
pAE1587 pJET1-tRNAAsp (D. discoideum) XhoI-T7pr-GCG-tRNAAsp-BamHI 
pAE1588 pJET1-tRNAAspC38A (D. discoideum) XhoI-T7pr-GCG-tRNAAspC38A-BamHI 
pAE1590 pSGP572a-pmt1 BglII-pmt1-SacII (intron-less pmt1
+-
sequence) 
pAE1666 pET15b-pmt1C81A XhoI-pmt1C81A-BamHI (intron-less pmt1+-sequence) 
pAE1688 pJET1-tRNAAsp (S. pombe) XhoI-T7pr-GCG-tRNAAsp-NcoI 
pAE1736 pJET1-tRNAAsp C38A (S. pombe) XhoI-T7pr-GCG-tRNAAspC38A-NcoI 
pAE1758 pJET1-tRNAGlu (S. pombe) XhoI-T7pr-GCG-tRNAGlu-NcoI 
pAE1820 pJET1-tRNALys (S. pombe) XhoI-T7pr-GCG-unspliced tRNALys-NcoI 
pAE1890 pSLF172-pmt1 nmtpr-XhoI-pmt1-BglII-HA-tag (intron-less pmt1+-sequence) 
pAE1891 pSLF172-prpmt1-pmt1 PstI-pmt1pr-XhoI-pmt1-BglII-HA-tag (intron-less pmt1+-sequence) 
 
Oligonucleotides used for gene deletions and plasmid constructions are listed in 
Table 5. Oligonucleotides were designed using ApE software and synthesized by 
Metabion. 
 
Table 5: Oligonucleotides used for gene deletion or plasmid generation 
Oligonucleotides Sequence 
K2 GCCCCTGAGCTGCGCACGTC 
K3 CTGCCCAGATGCGAAGTTAAGTGCGC 
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pJET-Seq.fw GGTATTATCTCTATTTTTAACTTGGAGCAGG 
pJET-Seq.rev GCCACCTACAACGGTTCC 
pmt1-BamHI.rev TCACGCGGATCCTTAGAAATTTAGAGGTTCCAGTAATAGAGA 
pmt1-BglII.fw AACGGAAGATCTATGCTTAGTACAAAAAGATTACGGGTCCT 
pmt1-C81A.fw GTAAATTATGGACTATGAGTCCCAGTGCTCAACCTTTTACTA
GAATAGGAAACC 
pmt1-C81A.rev CGGTTTCCTATTCTAGTAAAAGGTTGAGCACTGGGACTCATA
GTCCATAATTTAC 
pmt1-check.fw AACATTCCTAATTCTCGCAGTAGAT 
pmt1-check.rev GAGCCTAGCCAATCCATACC 
pmt1-KO.up GGTTACATTCAATGCTTAGTACAAAAAGATTACGGGTCCTGG
AGCTATATTCTGGCGTACGCTGCAGGTCGAC 
pmt1-NotI.rev TTTTCCTTTTGCGGCCGCCGAAATTTAGAGGTTCCAGTAATA
GAGAAATC 
pmt1-PCR1.fw2 GCCAATCTCTGTGAACGGG 
pmt1-PCR1.rev2 GGACCCGTAATCTTTTTGTACTAAGC 
pmt1-S2 AATATTAATTTCCTTTCATTTTAAAAAAATAGTTTTGACTTCTA
ACCGCTTTTAATCGATGAATTCGAGCTCG 
pmt1-S3 CGTTAAAGTTGTTTCATACTTGATTTCTCTATTACTGGAACCT
CTAAATTTCCGTACGCTGCAGGTCGAC 
pmt1-SacII 
neu.rev 
CGATCCCCGCGGCTGAAATTTAGAGGTTCCAGTAATAGAGA
AATC 
pmt1-Sew.fw2 CGAGCTCGAGATGTTCGTG 
pmt1-Sew.rev CCAGTGGAGGTTGGATGATTC 
pmt1-SmaI.fw ACTTCCCCCGGGATGCTTAGTACAAAAAGATTACGGGTCCT 
pmt1-XhoI.fw ACTCCGCTCGAGATGCTTAGTACAAAAAGATTACGGGTC 
pmt1.fw AAATCTAATGCAGGTAGGTC 
pmt1.rev GTCTTGAAATTAGTCCTGG 
REP.fw GATATGGATATTTATTAAATCAGGAAAAACGTAAC 
REP.rev GTGGTTTATAAAAATTCTTAACTACACCACT 
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For the generation of the pJET1 vectors for the in vitro transcription of tRNAs, the 
genes for tRNAAsp (SPATRNAASP.01), tRNAGlu (SPATRNAGLU.01), tRNALys 
(SPBTRNALYS.07) and the mutant tRNAAspC38A were cloned into an in vitro 
transcription vector. For this purpose, the PCR fragments with the sequences of 
S. pombe tRNAs were generated using four overlapping oligonucleotides in a single 
PCR reaction (Table 6). The resulting PCR fragments additionally contained XhoI 
and NcoI restriction sites, a T7 promoter sequence and a GCG trinucleotide that 
served as a start site for the T7 RNA polymerase. The DNA fragments were 
integrated into the pGEM-T easy vector (Promega), and subsequently cloned into 
pJET1-tRNAAsp (D. discoideum) vector (kind gift from W. Nellen) after excision of 
the Dictyostelium tRNAAsp sequence using XhoI and NcoI restricton sites. 
 
Table 6: Oligonucleotides used for transcription vector generation 
tRNAAsp   
Asp1 CTCGAGTTTTTCAGCAAGATTTGTAATACGACTCACTATAGCG
TCTCC 
Asp2 CGAACCCGGGCTGCAAGCGTGACAGGCTTGTGTACTACCCC
TATACTAAAGGAGACGCTATAGTGAGTCG 
Asp3 GCAGCCCGGGTTCGAATCCCGGAGGGAGAGCCATGG 
Asp4 CCATGGCTCTCCCTCC 
tRNAAspC38A   
Asp1 CTCGAGTTTTTCAGCAAGATTTGTAATACGACTCACTATAGCG
TCTCC 
AspC38A2 CGAACCCGGGCTGCAAGCTTGACAGGCTTGTGTACTACCCCT
ATACTAAAGGAGACGCTATAGTGAGTCG 
Asp3 GCAGCCCGGGTTCGAATCCCGGAGGGAGAGCCATGG 
Asp4 CCATGGCTCTCCCTCC 
tRNAGlu   
Glu1 CTCGAGTTTTTCAGCAAGATTTGTAATACGACTCACTATAGCG
TCCG 
Glu2 GAACCCCGACCGCGTCGGTGAAAGCGACGAATCCTAGCCGT
TGGACCACAACGGACGCTATAGTGAGTCG 
Glu3 CGCGGTCGGGGTTCGACTCCCCGCAACGGAGCCATGG 
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Glu4 CCATGGCTCCGTTGC 
tRNALys 
(unspliced) 
  
Lys1 CTCGAGTTTTTCAGCAAGATTTGTAATACGACTCACTATAGCG
TCCC 
Lys2 CGACTCACTATAGCGTCCCGAGTGGCTCAATCGGTTTAGAGC
GTCTGACTCTTACGAATGGTATCAGAAGGTTGCGAG 
Lys3 TGGTATCAGAAGGTTGCGAGTTCGAGTCTCGCCTTGGGAGC
CATGG 
Lys4 CGGAACCCTCGGTACC 
 
4.5 RNA purification 
Yeast cells were grown to an optical density OD600 of 0.5 - 0.9 in 50 mL cultures. 
Cells were harvested and the pellets were either stored at -20 °C or directly used for 
RNA preparation. Small sample numbers were prepared using 8 mL TriZol 
(Invitrogen) reagent per sample and glass beads. After vigorous shaking for 5 
minutes, the samples were centrifuged for 20 minutes at 12000xg to clear them from 
debris. The RNA was extracted using chloroform and precipitated with isopropyl 
alcohol.  
Larger sample numbers were prepared using 8 mL TriFast (PeqLab) reagent per 
sample and glass beads. After vigorous shaking for 5 minutes, the samples were 
transferred to PhaseTrap tubes (Peqlab), and an equal amount of chloroform was 
added. Centrifugation at 1500xg lead to a stable phase separation, and the RNA was 
precipitated from the supernatant with isopropyl alcohol. 
 
4.6 Transcription and purification of tRNAs 
In vitro transcribed tRNAs were obtained using T7 transcription kit (Fermentas) 
according to the suppliers instructions. Briefly, the vector containing the tRNA gene 
was linearized using NcoI (NEB) and 0.5 µg of this template DNA were incubated for 
2 hours at 37 °C with nucleotides and T7-RNA polymerase in the reaction buffer. The 
transcripts were treated with TURBO DNase (Ambion) for 15 min at 37 °C and 
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subjected to phenol/chloroform extraction and gel filtration using Sephadex G50 (GE 
Healthcare). 
 
4.7 In vitro RNA methylation Assay 
The activity of methyltransferases that use S-adenosyl-methionine (SAM) as a 
cofactor can be detected in an in vitro methylation assay, if the methyl group of SAM 
is labeled with a radioactive atom, e.g. with tritium. The labeled methyl group will be 
transferred to the appropriate substrate by an active methyltransferase. The 
radioactivity of the substrate can then be detected by autoradiography after gel 
electrophoresis of the reaction products. This assay also provides the possibility to 
analyze different proteins for their methylation activity and different RNA samples for 
their ability to be methylated.  
In vitro methylation of RNA samples was performed as described previously 
(Jurkowski et al. 2008). RNA extracts from S. pombe cells or in vitro transcribed 
tRNA were incubated with 3 µM of purified recombinant protein. The amounts of RNA 
varied from 2 µg to 10 µg of total RNA extracts, depending on the concentration of 
the sample, or were 0.5 µg for in vitro transcribed tRNA. The methylation reaction 
was composed as follows: 
 
X µL RNA 
2 µL 10x methylation buffer (50 mM Tris HCl pH 7.5, 50 mM NaCl, 
5 mM MgCl2, 1 mM DTT) 
1 µL Ribolock RNase Inhibitor (20 u/µL, Fermentas) 
2 µL S-[methyl-3H]-adenosyl-L-methionine (1 mCi/mL, Hartmann 
Analytic) 
Y µL recombinant DNA methyltransferase (final concentration 3 µM) 
Add water to 20 µL 
 
After 90 minutes of incubation at 22 °C, the reaction was stopped by the addition of 
1.2 u/µL Proteinase K (NEB) and 1 mM non-radioactive SAM (Sigma) and further 
incubated for 30-60 minutes. The samples where stored at -20 °C over night after 
addition of the RNA loading buffer  (10 mL formamide, 100 µL 0.5 M EDTA, 
Bromophenol blue). 
The denaturating 7 M urea 12 % polyacrylamide gel (5 mL 10x TBE, 21 g urea, 
15 mL Rotiphorese Gel 40 (19:1), 15 mL water, 100 µL TEMED, 100 µL 10 % APS) 
was run for 30 minutes at 24-28 mA before loading the samples. The samples were 
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heated to 80 °C for 5 minutes, loaded onto the gel and separated for 3-5 hours at 24-
28 mA. The gel was then stained with EtBr for 20 minutes and documented before it 
was fixed with a solution containing 10 % acetic acid and 10 % methanol twice for 
10 minutes. Incubation in amplify solution for 1 hour was followed by drying the gel in 
a gel dryer at 70 °C. An autoradiography film (GE Healthcare) was then exposed to 
the gel at -80 °C over night up to several days. 
 
4.8 RNA bisulfite sequencing 
When RNA is treated with bisulfite, non-methylated cytosines will be deaminated to 
uracil, whereas methylated cytosines will not be affected by the treatment. When the 
bisulfite-treated RNA is then converted into cDNA, amplified by PCR and sequenced, 
methylated cytosines will be sequenced as cytosines in the sequence, whereas 
unmethylated RNA-cytosines will appear as thymines after sequencing. This method 
thus allows the detection of RNA methylation in a given substrate. 
RNA bisulfite sequencing was performed according to protocols published elsewhere 
(Schaefer et al. 2009b). Briefly, 2 µg of total RNA were treated with 2 u/µL TURBO 
DNase (Ambion) in a total sample volume of 10 µL for 30 minutes at 37 °C. The 
DNase was inactivated with DNase inactivation reagent (Ambion) by incubation at 
room temperature for 5 minutes and centrifugation at 10000xg. 42.5 µL Bisulfite Mix 
(Epitect Bisulfite Kit, Qiagen) and 17.5 µL stabilization solution (Qiagen) were added 
to the 10 µL of each sample to give a final volume of 70 µL, and it was incubated for 
the bisulfite reaction (5 minutes at 70 °C, 3 hours at 60 °C, cool down to 20 °C). The 
samples were desalted using Micro-Bio-Spin columns (Bio-Rad) and then incubated 
with 70 µL of 1 M Tris (pH 9) at 37 °C for 1 hour for desulphonation of RNA adducts. 
After addition of 1/10 sample volume 3 M sodium acetate, 20 µg glycogen and 
420 µL ethanol, the RNA was precipitated at -80 °C over night. 
The precipitated RNA was pelleted, washed and dissolved in 10 µL DEPC treated 
water. The concentration of the RNA was determined using a spectrophotometer. For 
cDNA synthesis, 500 ng of bisulfite-treated RNA were mixed with 2 µL of 10 mM 
dNTP mix (Superscript III, Invitrogen) and 1 µL of 10 µM tRNA-specific RT-primer in 
a total volume of 13 µL and incubated at 70 °C for 5 minutes. After addition of 2.3 µL 
of 10x RT buffer, 4 µL of 25 mM MgCl2, 2 µL of 0.1 M DTT, 1 µL RNase inhibitor and 
1 µL Superscript III reverse transcriptase (total volume of 23 µL), the samples were 
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incubated for 10 minutes at 25 °C, 50 minutes at 50 °C, 15 minutes at 94 °C and 
cooled down to 4 °C. 1 µL of cDNA was then used for PCR amplification [3 min 
96 °C, (30 sec 96 °C, 45 sec 45 °C, 45 sec 68 °C) x35 cycles, 5 min 70 °C, cool 
down to 4 °C], the amplicon was purified from an agarose gel using the QiaQuick Gel 
extraction Kit (Qiagen) and cloned into the pGEM-T easy vector (Promega) for 
sequencing. Individual clones were purified using QiaPrep Spin Miniprep Kit (Qiagen) 
and sequenced at GATC Biotech. The five nucleotides with random sequences that 
were included in the primers used for reverse transcription (Table 7) provided a 
possibility to identify independent clones in the RNA methylation analysis. 
 
Table 7: Oligonucleotides used for RNA bisulfite sequencing 
Name Sequence 
stemloop.rev CTCAACTGGATTGGCT 
tRNAAsp   
Asp RT-Primer CTCAACTGGATTGGCTNNNNNGATAAATCCAGTTGAGTGGCTCTCCCTC 
Asp bisulfite.fw TTAGTATAGGGGTAGTATAT 
tRNAGlu   
Glu RT-Primer CTCAACTGGATTGGCTNNNNNGATAAATCCAGTTGAGTGGCTCCATTACA 
Glu bisulfite.fw TTTGTTGTGGTTTAATGGT 
tRNAHis   
His RT-Primer CTCAACTGGATTGGCTNNNNNGATAAATCCAGTTGAGTGGTACCCACACCA 
His bisulfite.fw ATATGGTTTAGTGGTTAAGAT 
tRNALeu   
Leu RT-Primer CTCAACTGGATTGGCTNNNNNGATAAATCCAGTTGAGTGGTAAAAAATAT 
Leu bisulfite.fw TTGTTTGAGTGGTTATGGAGT 
tRNALys   
Lys RT-Primer CTCAACTGGATTGGCTNNNNNGATAAATCCAGTTGAGTGGCTCCCAAAA 
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Lys bisulfite.fw GTGGTTTAATTGGTTTAGAGT 
tRNAVal   
Val RT-Primer CTCAACTGGATTGGCTNNNNNGATAAATCCAGTTGAGTGGTACATCTAC 
Val bisulfite.fw AGTTTAGTGGTTATGATTTT 
 
4.9 SDS-PAGE and Western Blotting 
Proteins were separated by SDS-PAGE in Tris-glycine buffer at 120 V according to 
standard protocols (Laemmli 1970). Gels were stained using coomassie blue or silver 
staining (SilverStain Plus, Bio-Rad) according to the manufacturer’s instructions. 
Protein transfer to nitrocellulose membranes (Bio-Rad) was accomplished by blotting 
with the Bio-Rad Tank Transfer System in blot buffer (25 mM Tris, 52 mM glycine, 
10 % methanol) at 120 V for 90 min. The membrane was blocked for 2 hours in 
5 % milk/TBS-T (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.1 % Tween-20, 5 % dry 
milk powder). Incubation with the primary antibody was over night at 4 °C in 
5 % milk/TBS-T, and incubation with the secondary antibody was for 2 hours at room 
temperature in 5 % milk/TBS-T (concentrations see below). The blot was washed 
5 times for 5 minutes with TBS-T (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 
0.1 % Tween-20), and the western blot signals were detected using ECL Western 
Blotting Analysis System (GE Healthcare) and Hyperfilm ECL (GE Healthcare). 
Primary epitope tag antibodies were obtained from Sigma (Peroxidase Anti-
Peroxidase complex 1:1000, α-polyHistidine 1:3000) and Millipore (α-CBP 1:2000). 
Secondary antibodies conjugated to horseradish peroxidase were purchased from 
Sigma (sheep α-mouse 1:1000, goat α-rabbit 1:1000) 
 
4.10 Purification of recombinant Dnmt2 proteins 
Proteins carrying a hexa-histidine peptide tag can efficiently be purified using 
immobilized metal affinity chromatography (IMAC (Hochuli 1988)). This purification 
relies on the affinity of a molecule for a certain metal, which is immobilized onto a 
chelating surface, and allows for purification under native as well as denaturating 
conditions.  
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For protein purification, 500 mL of LB medium containing 100 µg/mL ampicillin and 
34 µg/mL chloramphenicol were inoculated with Rosetta E. coli strains carrying the 
expression vector. The cells were grown to an OD600 of 0.6, and protein expression 
was subsequently induced with 1 mM IPTG for 1-3 hours before the cells were 
harvested at 4000 rpm and stored at -20 °C. The cells were lysed in sonication buffer 
(30 mM potassium phosphate buffer (KPi) pH 7.0, 300 mM KCl, 10 % glycerol, 
0.1 mM DTT, complete Protease Inhibitor Cocktail (Roche)) by repeated addition of 
small amounts of lysozyme and sonification for 10 minutes using 30 sec intervals 
until the lysate was almost clear.  
The protein was purified using Profinity IMAC Ni-charged resin (Bio-Rad) in 
sonication buffer containing 10 mM imidazole and eluted from the beads using 
elution buffer containing 200 mM imidazole (30 mM KPi pH 7.0, 300 mM KCl, 10 % 
glycerol, 0.1 mM DTT, 200 mM imidazole). Purification was followed by dialysis in 
dialysis buffer I (30 mM KPi pH 7.0, 200 mM KCl, 20 % glycerol, 0.1 mM EDTA, 
1 mM DTT) and dialysis buffer II (30 mM KPi pH 7.0, 100 mM KCl, 50 % glycerol, 
0.1 mM EDTA, 1 mM DTT), and the final protein concentration was determined using 
Bradford reagent (Bio-Rad) according to the manufacturer’s instructions. Typical 
protein concentrations ranged from 20 µM to 90 µM. 
 
4.11 Purification of native protein by Tandem-Affinity Purification 
(TAP) 
The Tandem Affinity Purification (TAP) method is based on a protein tag that consists 
of three essential parts (Rigaut et al. 1999; Puig et al. 2001). The protein A part of the 
TAP tag is able to bind to IgG columns, whereas the CBP (calmodulin binding 
protein) module is able to bind calmodulin beads. The two protein sequences are 
separated by a TEV (tobacco etch virus) protease cleavage site that allows for 
elution from an IgG column by TEV cleavage, which shortens the protein tag by the 
protein A part. The major advantage of this purification is the possibility of purifying a 
protein under mild native conditions, which allows for copurification of associated 
factors. 
S. pombe cells were cultured in 6 L YES medium to an OD600 of 1.5-2. The cells were 
harvested, the pellet was washed with ice-cold water, resuspended in buffer A 
(10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 2 mM 
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benzamidine, complete Protease Inhibitor Cocktail (Roche)) and frozen at -80 °C. For 
protein extraction, the pellet was thawed, and the cells were lysed using a French-
Press. Subsequently, the amount of KCl was adjusted to a final concentration of 
260 mM. Debris and supernatant were separated by ultracentrifugation (30 min at 
21000 rpm, 2 h at 30000 rpm). TAP-tagged proteins were extracted using two 
sequential column materials. The first purification was with rabbit IgG agarose beads 
(Sigma) that were equilibrated with IPP150 buffer (10 mM Tris/HCl pH 8.0, 150 mM 
NaCl, 0.1 % Nonidet (NP-40)). The protein was eluted from the column using AcTEV-
protease (Invitrogen) at a final concentration of 0.1 u/µL in a final volume of 1 mL 
TEV cleavage buffer (10 mM Tris/HCl pH 8.0, 150 mM NaCl, 0.1 % Nonidet, 0.5 mM 
EDTA, 1 mM DTT) for 2 hours at 16 °C. The eluate was then applied to a calmodulin 
sepharose column (GE healthcare) that had been equilibrated with calmodulin 
binding buffer (10 mM Tris/HCl pH 8.0, 10 mM 2-mercaptoethanol, 150 mM NaCl, 
1 mM magnesium acetate, 1 mM imidazole, 2mM CaCl2, 0.1 % Nonidet). The protein 
was eluted with EGTA using Calmodulin elution buffer (10 mM Tris/HCl pH 8.0, 
10 mM 2-mercaptoethanol, 150 mM NaCl, 1 mM magnesium acetate, 1 mM 
imidazole, 0.1 % Nonidet, 2mM EGTA pH 8.0). The eluate was concentrated by 
centrifugation in Centricon tubes (Millipore) according to the supplier’s instructions. 
The concentrated eluate was then analyzed by SDS-PAGE, Western Blot analysis 
and Silver staining. 
 
4.12 Chronological lifespan assay 
For a quantitative determination of chronological lifespan, S. pombe cells were 
cultured in 50 mL or 100 mL complete medium or minimal medium for several weeks 
at 30 °C. After 2-3 days, when the culture had reached stationary phase according to 
the measured OD600, samples of the aged culture were taken at regular intervals and 
serially diluted. At least 4 different dilutions for every culture were plated onto YES 
medium plates and incubated at 30 °C for 3 days. The number of colonies on each 
plate was counted, and the amount of colony-forming units (CFU) was determined for 
each culture.  
For qualitative determination of chronological lifespan, S. pombe cells were cultured 
in 6 mL complete medium or minimal medium for several weeks at 30 °C. After 2-3 
days, when the culture had reached stationary phase according to the measured 
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OD600, samples of the aged culture were taken at regular intervals and serially diluted 
in 1:6 dilution steps, spotted onto YES plates and incubated at 30 °C for 3 days. 
  
4.13 Synthetic Genetic Array 
Synthetic lethality describes the phenomenon that two non-essential mutations 
become essential when they are combined. This effect gives indications as to 
overlapping functions of the two mutant genes and genetically places them in parallel 
pathways.  
In a Synthetic Genetic Array (SGA), the combination of a certain mutation with many 
different other mutations is screened for synthetic lethality. This can be achieved by 
utilization of a collection of strains that contain deletions of non-essential genes 
(deletion library). Each of the mutations from the library is combined with a deletion of 
the gene of interest. Such high-throughput screens require special features in the 
strain background of the yeast cells that allow for large-scale selection of haploid 
single and double mutants. The establishment of the Pombe Epistasis Mappers and 
the availability of an S. pombe deletion library (Bioneer) that contained deletions of 
approximately 3000 non-essential genes provided all the necessary features for a 
synthetic genetic array (Roguev et al. 2007). 
 
Figure 8: Selection strategy applied in this study 
The cycloheximide sensitive (cyhS) allele that was inserted in the h- mating type locus (MTL) allowed 
for selection against h- cells after the cross. The combination of the cyhS allele with a recessive 
cycloheximide resistance allele (cyhR) in this h- strain mimics the genotype of a heterozygous diploid 
cell and allows for anti-diploid and mating-type selection after the cross (modified from (Roguev et al. 
2007)). 
 
The selection of haploid double deletion strains of a specific mating type is based on 
the genotype of the Pombe Epistasis Mapper (PEM) strains (Roguev et al. 2007). For 
this study we chose to perform the selection using the strain PEM2. PEM2 has an h- 
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mating type and is modified with the insertion of a wild type rpl42 (cyhS) allele into the 
mating type locus, which causes cycloheximide sensitivity. This strain additionally 
has a recessive rpl42(sP56Q) allele that provides cycloheximide resistance inserted 
in the genome. When this strain is crossed with an h+ strain that is cycloheximide 
sensitive and the sporulation products are selected for cycloheximide resistance, only 
haploid cells that contain the cycloheximide resistance allele can survive. These 
haploids also have to be h+ cells, because cycloheximide selects against the 
sensitive h- mating type locus.  
The gene deletions in the deletion library were marked with the kanMX marker gene 
that provides resistance to the antibiotic G418. The pmt1+ deletion was introduced 
into in the PEM2 strain and marked with the natMX marker gene that provides 
resistance against the antibiotic nourseothricin. When the selection against one or 
both of these deletions was combined with the cycloheximide selection, the surviving 
cells were either haploid single mutants carrying the deletion from the library 
(cycloheximide + G418), or haploid double mutants carrying the deletion from the 
library and the pmt1+ deletion (cycloheximide + G418 + nourseothricin). When the 
sporulation products contained viable single mutants, but no viable double mutants, 
this indicated a synthetic lethal interaction.  
The SGA was performed according to the protocol published by (Roguev et al. 2007). 
Briefly, yeast cells of opposing mating types (AEP37 x Bioneer deletion library) were 
mixed in microtiter plates and transferred to sporulation plates (SPAS, Table 1) using 
a replica tool. The plates were incubated for 4 days at 23 °C. Next, the cells were 
transferred to complete medium plates (YES) for spore germination and incubated for 
one day at 30 °C, before the cells were replica plated onto complete medium 
containing cycloheximide and G418 (YES+GC) for selection for haploid single 
mutants (incubation at 30 °C for two days). In a final step, the yeast cells were 
transferred to complete medium containing cycloheximide, G418 and nourseothricin 
(YES+GNC) for double mutant selection. The plates were incubated at 30 °C for two 
days and documented. Comparison of growth on YES+GC and growth on YES+GNC 
identified gene deletions that affected cell growth in combination with a pmt1+ 
deletion. 
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4.14 S. pombe crosses and tetrad dissection 
Cell material of the two strains to be crossed was mixed on a SPAS plate and 
incubated at room temperature for two days. S. pombe cells mate and sporulate 
spontaneously under these conditions. Asci were transferred to YES plates, identified 
under a microscope, separated and incubated at 37 °C for 3-5 hours or over night at 
room temperature to allow for break-down of the ascus wall. Afterwards, the spores 
were separated by micromanipulation and incubated at 30 °C for 2-3 days. The 
markers of the segregants were tested by replica plating onto appropriate selective 
medium. 
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5 Results 
5.1 Pmt1 methylated heterologous tRNAAsp in vitro 
Dnmt2 homologs from various species have tRNA methyltransferase activity. Despite 
the fact that Pmt1 was the first member of the Dnmt2 family to be identified, the RNA 
methyltransferase activity of the S. pombe homolog has not yet been investigated. In 
this study we wanted to investigate the activity of Pmt1 based on the findings on 
other Dnmt2 homologs. 
In a first approach, we sought to determine in vitro methylation activity of Pmt1 on 
substrates that are methylated by other Dnmt2 homologs. Recombinant Dnmt2 
proteins can be used to methylate tRNA substrates in an in vitro methylation reaction. 
We therefore sought to determine whether recombinant Pmt1 could methylate known 
Dnmt2 substrates in vitro. To this end, we purified 6xHis-tagged Pmt1 from E. coli. 
The protein was soluble and could be purified under native conditions in sufficient 
amounts for the application in an in vitro methylation assay. Coomassie staining and 
western blot analysis confirmed the purification of a 39 kDa protein (Figure 9A) – the 
expected size for hexa-histidine-tagged Pmt1 – that was detectable using an eptitope 
tag antibody (Figure 9B). 
 
 
Figure 9: Purification of hexa-histidine tagged Pmt1 
(A) Samples from different steps of the His6-purification were separated by SDS-PAGE in an 8 % 
SDS-gel. Coomassie staining visualized the protein bands. His6-tagged Pmt1 is expected at 39 kDa. 
1= Marker, 2=Flowthrough after Ni-beads, 3=Concentrated eluate, 4=Eluate 60 mM imidazole 
fraction 1, 5=Eluate 60 mM imidazole fraction 5, 6=Eluate 100 mM imidazole fraction 1, 7=Eluate 
100 mM imidazole fraction 5 (B) Samples from different steps of the His6-purification were separated 
by SDS-PAGE and visualized by Western blotting. Anti-histidine-tag antibody detected His6-Pmt1 at 
39 kDa. 1=Flowthrough after Ni-beads, 2=Eluate 60 mM imidazole fraction 1, 3=Eluate 60 mM 
imidazole fraction 3, 4=Eluate 60 mM imidazole fraction 5, 5=Eluate 100 mM imidazole fraction 1, 
6=Eluate 100 mM imidazole fraction 3, 7=Eluate 100 mM imidazole fraction 5, 8=Concentrated eluate. 
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Dictyostelium discoideum tRNAAsp has been identified as a substrate for the 
D. discoideum homolog of Dnmt2, DnmA. This tRNAAsp, like all other known Dnmt2 
substrates, contains a cytosine at position 38 in the anticodon loop, which is the 
methylation target of tRNA methylation by Dnmt2 enzymes. In an in vitro methylation 
assay, not only DnmA, but also human Dnmt2 can methylate the tRNAAsp from 
D. discoideum (S. Müller, W. Nellen, unpublished data). Therefore, we used in vitro 
transcribed tRNAAsp from D. discoideum as a substrate to ask whether Pmt1 can also 
methylate this tRNA (in collaboration with Sara Müller and Wolfgang Nellen, 
Department for Genetics, University of Kassel).  
The in vitro methylation assay is based on the fact that m5C-methyltransferases use 
S-adenosyl-methionine (SAM) as a cofactor. In the assay, a radioactively labeled 
SAM was used that contained a tritiated methyl group. During the methylation 
reaction, this radioactive methyl group is transferred to the substrate, and the 
radioactively labeled substrate can then be detected by autoradiography (Jurkowski 
et al. 2008). As expected, the previously characterized methylation activity of DnmA 
and human Dnmt2 on tRNAAsp could be detected (Figure 10). Significantly, Pmt1 was 
able to methylate the tRNAAsp substrate to a similar degree as DnmA and hDnmt2. 
This demonstrated that Pmt1, like other Dnmt2 enzymes, has in vitro tRNA 
methyltransferase activity. This activity was found on an in vitro transcribed tRNAAsp 
substrate that carried no other modifications, implicating that previous modification of 
the substrate is not required for in vitro activity of Pmt1. Furthermore, this showed 
that the mutation in the amino acid sequence of the catalytic motif IV (PPCQ  
PSCQ), which was thought to be responsible for the absence of a detectable DNA 
methyltransferase activity in Pmt1 did not abrogate tRNAAsp methylation activity in 
vitro. 
The activity of Dnmt2 enzymes is specific to a cytosine residue at position 38 of the 
anticodon loop, and this is the only position known to be methylated by Dnmt2 
enzymes. To determine the methylation site within the D. discoideum tRNAAsp 
sequence, we also tested the ability to methylate a mutated tRNAAsp substrate 
(tRNAAspC38A), which did not contain the cytosine at position 38. Pmt1 was unable 
to methylate this tRNA (Figure 10), showing that Pmt1 methylated the D. discoideum 
tRNAAsp at position C38. 
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Figure 10: Pmt1 methylates D. discoideum tRNAAsp at position C38. 
In vitro transcribed tRNAAsp (500 ng) or tRNAAspC38A (500 ng) from Dictyostelium discoideum was 
incubated with different Dnmt2 homologs (Pmt1: 3-12 µM, DnmA: 3 µM, hDnmt2: 3 µM). The samples 
were separated by urea-PAGE and in vitro methylation was detected by autoradiography. 
Recombinant DnmA and Dnmt2 were courtesy of Sara Müller and Wolfgang Nellen. 
 
5.2 Pmt1 methylated S. pombe tRNAAsp in vitro 
We next sought to determine whether the ability of Pmt1 to methylate tRNAs is 
extended to the native tRNAAsp from S. pombe. Therefore, we analyzed the tRNAAsp 
gene of S. pombe for the properties required for Dnmt2 target recognition. As in other 
known Dnmt2 substrate tRNAs, we found that S. pombe tRNAAsp also contains a 
cytosine at position 38 in the anticodon loop. Thus, it could in principle be a substrate 
for a Dnmt2 homolog.  
The S. pombe tRNAAsp sequence or a mutated sequence coding for tRNAAspC38A 
were transcribed in vitro and applied as substrates in the methylation assay. 
Recombinant Pmt1 was able to methylate the S. pombe tRNAAsp substrate, as 
detected by a strong methylation signal. In contrast, the mutated tRNA could not be 
methylated (Figure 11A). This demonstrated that recombinant Pmt1 methylates 
S. pombe tRNAAsp at position C38 in vitro. As for the D. discoideum tRNAAsp, no 
previous modifications on the tRNA were necessary to detect Pmt1 activity on the 
substrate. 
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Figure 11: Pmt1 methylates S. pombe tRNAAsp at position C38. 
(A) In vitro transcribed tRNAAsp (500 ng) or tRNAAspC38A (500 ng) from Schizosaccharomyces pombe 
was incubated with 3 µM Pmt1 or 3 µM Pmt1C81A. The samples were separated by urea-PAGE and 
in vitro methylation was detected by autoradiography. (B) The amounts of purfied protein were 
compared by SDS-PAGE. Coomassie staining visualized His6-Pmt1 and His6-Pmt1C81A at 39 kDa 
and His6-hDnmt2 at ~46 kDa. 
 
When recombinant proteins are used for activity assays, there is always the 
possibility that the detected activity originates from a contaminant that has been 
copurified with the enzyme of interest. To investigate the methylation activity of 
possible contaminants, we constructed a catalytically inactive Pmt1 mutant. In this 
protein, the catalytic cysteine in motif IV was exchanged by an alanine, which is 
expected to abrogate the methyltransferase activity of Pmt1. The mutant protein was 
purified from E. coli and used in the methylation assay. The amounts of protein used 
in the assay were compared using SDS-PAGE and coomassie staining (Figure 11B). 
Importantly, the mutant protein was not able to methylate any of the tRNAAsp 
substrates (Figure 11A). This result showed that the methylation activity detected on 
tRNAAsp resided in Pmt1 and not in a copurifying contaminant. 
 
5.3 Pmt1 methylated S. pombe tRNAGlu in vitro 
Dnmt2 homologs have the ability to methylate tRNAs other than tRNAAsp that contain 
a cytosine at position 38. In Drosophila, tRNAGly and tRNAVal are methylated at 
position C38 (Schaefer et al. 2010), and in D. discoideum, tRNAGlu is a target for 
methylation by the Dictyostelium Dnmt2 homolog DnmA (W. Nellen, personal 
communication). To determine whether Pmt1 is also able to methylate other 
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S. pombe tRNAs, we identified all tRNAs of the fission yeast containing a C38 
(Table 8). Due to a proposed “target recognition motif” that includes the bases at the 
positions 32, 37, 38 and 40 (M. Helm, unpublished data), we also compared the C38-
containing tRNA sequences for the bases at these positions. According to the 
proposed motif, Dnmt2 enzymes require a cytosine at position 32 in the anticodon 
loop, an adenine at position 37, a cytosine at position 38 and another cytosine in the 
anticodon stem at position 40.  
 
Table 8: S. pombe tRNAs containing a C38 
tRNA C32 A37 C38 C40 
Asp + + + + 
Glu + + +   
Lys unspliced + + +   
Val   + + + 
Leu     + + 
His     +   
Lys + +     
 
 
We chose to investigate tRNAGlu and the unspliced tRNALys as substrates for 
recombinant Pmt1, because they contain all but one of the bases hypothesized to be 
important for target recognition and subsequent activity of Dnmt2 enzymes. The only 
tRNA in S. pombe with a perfect match to the pattern is tRNAAsp. In vitro transcripts 
of these two tRNAs were used as substrates in the methylation reaction. As a result, 
we found that tRNAGlu can be methylated by Pmt1, but to a much lesser extent than 
tRNAAsp (Figure 12). Pmt1 was unable to methylate the unspliced tRNALys 
(Figure 12), although it contains all the same bases of the recognition pattern as 
tRNAGlu. This suggested that proper folding of the tRNA, which is probably not 
present in the unspliced tRNALys, is another important factor of Pmt1 target 
recognition. 
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Figure 12: Pmt1 methylates S. pombe tRNAGlu. 
In vitro transcribed tRNAs (500 ng) were incubated with Pmt1 (3 µM). The samples were separated by 
urea-PAGE and in vitro methylation was detected by autoradiography. 
 
5.4 Pmt1 had methyltransferase activity in vivo 
Since we had observed that Pmt1 has tRNA methyltransferase activity in vitro, we 
next asked whether the enzyme is also active in the yeast cells. To this end, we used 
RNA bisulfite sequencing. This method has been derived from the commonly used 
DNA bisulfite sequencing method, but adapted to the needs of RNA samples 
(Schaefer et al. 2009b). It allows for direct analysis of methylation patterns on native 
RNA. We extracted RNA from S. pombe strains, treated it with bisulfite and 
generated PCR amplicons of tRNAAsp. Individual independent clones were analyzed 
by sequencing to determine methylation at cytosine residues.  
To ensure high cellular Pmt1 protein levels (and for reasons that will become obvious 
below), we expressed pmt1+ from the nmt1 overexpression promoter by using a 
pmt1Δ-strain that carried either a control vector or an overexpression vector and 
cultured them in S. pombe minimal medium (EMM) to ensure maintenance of the 
plasmids. The pmt1Δ background was used to provide a situation with unmethylated 
tRNAAsp as a control. The overexpression of the protein should force Pmt1 into 
action. The RNA isolated from these strains was treated with bisulfite, reverse 
transcribed, amplified by PCR and cloned for sequencing.  
Significantly, upon pmt1+-overexpression, the methylation of position C38 of tRNAAsp 
was 100 % (Figure 13). We detected methylation at positions C48, C49, C60, C61 
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and C62, which are carried out by other tRNA-methyltransferases, which indicated 
that the bisulfite reaction was successful and that methylated cytosines are not 
converted to uracil by the bisulfite treatment. This provided further evidence for the 
methylated state of cytosine 38 in this strain. As expected, we found no methylation 
at position C38 in the pmt1Δ-strain. The other methylation sites of tRNAAsp were 
unaffected by the change in pmt1+-expression. This result for the first time 
demonstrated in vivo Pmt1 activity on a tRNAAsp substrate.  
We also wanted to determine the level of methylation in a wild-type strain. Thus, 
tRNAAsp from a wild-type strain carrying either a control or an overexpression vector 
was also analyzed by RNA bisulfite sequencing. We were able to detect cytosine 
methylation at position C38 in 23 % of the analyzed clones when the cells carried the 
control plasmid. As expected from the results above the methylation level was 100 % 
upon pmt1+-overexpression. This result provided evidence for in vivo Pmt1 activity on 
tRNAAsp at the endogenous expression level (Figure 13). 
              
Figure 13: Pmt1 methylates tRNAAsp in vivo. 
Bisulfite analysis of tRNAAsp from wild type or pmt1Δ cells carrying either a control plasmid or a pmt1+-
overexpression plasmid. Each column represents a cytosine of tRNAAsp, each line represents an 
individual clone. Methylated cytosines are indicated by black boxes, grey boxes mark unmethylated 
C38.  
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To validate these findings with an independent method, we used the in vitro 
methylation assay to detect RNA methylation in cellular RNA. The recombinant Pmt1 
enzyme in the in vitro methylation reaction was able to methylate – and therefore 
radioactively label – all substrates in the total RNA sample that are unmethylated 
upon extraction from the yeast cells. RNA substrates that have already been 
methylated in vivo in the cells cannot be methylated in the in vitro reaction. 
Consequently, completely unmethylated RNA samples are expected to give a 
detectable band in the in vitro methylation, whereas RNA fully methylated in vivo is 
expected to give no detectable signal for the in vitro methylation. If only a fraction of 
the RNA substrates was methylated in vivo, a reduced methylation signal is expected 
in the in vitro methylation reaction. We used total RNA isolated from a wild-type strain 
and a pmt1+-overexpression strain as substrates for an in vitro methylation reaction 
(Figure 14). 
                                 
Figure 14: In vivo methylation upon pmt1+-overexpression is confirmed by in vitro methylation. 
Total RNA extracts from wild type or pmt1+-overexpression strain were incubated with 3 µM Pmt1. The 
samples were separated by urea-PAGE and methylation signals were detected by autoradiography. 
tRNAAsp and tRNAAspC38A served as controls for the methylation reaction. 
 
In agreement with the results from the bisulfite sequencing, we detected a strongly 
reduced methylation signal for the pmt1+-overexpression strain compared to the wild-
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type strain. The ethidiumbromide (EtBr) stained gel showed that similar amounts of 
total RNA were used in the in vitro methylation reaction (Figure 14). Since equal EtBr 
signals indicate equal RNA amounts in the samples, changes in the signal strength of 
the autoradiography indicate changes in the amount of methylated Pmt1 substrates. 
For this experiment, this suggested that in the pmt1+-overexpression strain there is in 
vivo methylated RNA that subsequently is unavailable for methylation by the 
recombinant enzyme in the in vitro reaction. Although the observed methylation 
signal for the pmt1+-overexpression strain was lower than in the wild-type strain, 
there was still a detectable signal left. This was surprising, because we found 100 % 
methylation of tRNAAsp in the overexpression strain by RNA bisulfite sequencing, and 
it therefore indicated that there are other small RNAs besides tRNAAsp in the total 
RNA extracts that can be methylated by recombinant Pmt1, but not by the 
overexpressed enzyme in the cells. 
We knew from the previous experiments with the in vitro tRNA transcripts that Pmt1 
is able to methylate substrates other than tRNAAsp, although to a lesser extent. We 
therefore hypothesized that the residual signal in the overexpression strain resulted 
from the in vitro methylation of previously unmethylated tRNAGlu. To test this 
hypothesis, we performed RNA bisulfite sequencing of RNA extracted from the 
pmt1+-overexpression strain, and analyzed the methylation level of tRNAGlu. We 
detected a methylation level of 25 % of the analyzed clones of tRNAGlu (Figure 15). 
This showed that Pmt1 was able to methylate less favorable substrates in vivo, but to 
a lower level than the tRNAAsp substrate. 
       
Figure 15: In vivo methylation of tRNAGlu upon pmt1+-overexpression 
Bisulfite analysis of tRNAGlu from pmt1Δ cells carrying a pmt1+-overexpression plasmid. Each column 
represents a cytosine of tRNAGlu, each line represents an individual clone. Methylated cytosines are 
indicated by black boxes, grey boxes mark unmethylated C38.  
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These data explained the residual signal in the pmt1+-overexpression strain in the in 
vitro methylation assay. The recombinant enzyme in the in vitro reaction could 
methylate the residual 75 % of tRNAGlu that was not methylated in vivo. Thus, at least 
a fraction, if not all, of the methylation signal detected after in vitro methylation of total 
RNA from the pmt1+-overexpression strain could be explained by methylation of 
previously unmethylated tRNAGlu by the recombinant enzyme.  
We also sought to test the methylation status of all the other tRNAs of S. pombe that 
contain a cytosine at position 38 (Table 8). For this purpose, we performed RNA 
bisulfite sequencing for all of these tRNAs. We were unable to evaluate the data for 
the methylation in tRNAHis, tRNAVal, tRNALys and tRNALeu due to technical reasons 
(data not shown). The sequences that were cloned after the bisulfite treatment and 
the reverse transcription were incomplete. The region of interest, the anticodon loop, 
was missing in most of the analyzed clones. A possible explanation could be the 
extensive modification of many tRNAs that could interfere with the reverse 
transcription of the tRNAs. 
 
5.5 In vivo tRNA methylation by Pmt1 was depended on nutrient 
conditions 
The previous experiments on the methylation level of tRNAAsp in the yeast cells 
indicated that tRNA methylation by Pmt1 was limiting under certain conditions, 
because we detected only approximately 25 % methylation of tRNAAsp at position 
C38 in the wild-type strain. We hypothesized that nutrient conditions might limit 
Pmt1-dependent methylation of tRNAAsp in vivo. 
To test this hypothesis, we cultured wild-type and pmt1Δ cells in S. pombe complete 
medium (YES). In this medium, nutrient availability should not be limited. We 
performed bisulfite sequencing of RNA extracted from these cultures and analyzed 
tRNAAsp methylation. Positions C48 and C49 were constitutively methylated, 
regardless of the presence of pmt1+. This indicated that the bisulfite conversion did 
not affect methylated cytosines and verified the results that were found for the 
methylation at position C38. As expected, the pmt1Δ-strain showed no methylation at 
position C38 of tRNAAsp. If limited nutrients would lead to limited Pmt1 activity, the 
tRNA methylation in a wild-type strain should increase in a complete medium. To our 
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surprise, the RNA extracted from wild-type cells also had no methylated cytosines at 
position C38 of tRNAAsp (Figure 16). 
                     
Figure 16: tRNAAsp is not methylated in cells cultured in S. pombe complete medium 
Bisulfite analysis was performed for tRNAAsp from wild type or pmt1Δ cells cultured in YES medium. 
Each column represents a cytosine of tRNAAsp, each line represents an individual clone. Methylated 
cytosines are indicated by black boxes, grey boxes mark unmethylated C38. 
 
Serendipitously, preliminary experiments on RNA methylation in S. pombe cells in 
our laboratory were carried out on RNA that was extracted from cells cultured in 
complete medium from another yeast species, Saccharomyces cerevisiae. These 
experiments suggested that there was Pmt1-dependent tRNA methylation under 
these conditions. Thus, we cultured wild-type and pmt1Δ cells in S. cerevisiae 
complete medium YPD and analyzed RNA extracted from these cultures for tRNAAsp 
methylation using RNA bisulfite sequencing. The methylation at positions C48 and 
C49, which could be detected reliably, served as an internal control for the results 
found for the methylation at position C38. The pmt1Δ-strain displayed no tRNAAsp 
methylation at position C38, which was expected due to the absence of Pmt1. 
Surprisingly, we could detect almost 100 % of tRNAAsp methylation in the wild-type 
strain in this medium (Figure 17). The strong difference in tRNAAsp methylation 
between cells cultured in YES (S. pombe medium) or YPD (S. cerevisiae medium) 
could be attributed to changes in Pmt1 activity. Whether this alteration in Pmt1 
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and glucose. The amount of each ingredient is different in both media. YPD also 
contains peptone, a component that causes slightly delayed growth of S. pombe 
cells. 
 
                 
Figure 17: tRNAAsp is methylated in cells cultured in S. cerevisiae complete medium 
Bisulfite analysis was performed for tRNAAsp from wild type or pmt1Δ cells cultured in YPD medium. 
Each column represents a cytosine of tRNAAsp, each line represents an individual clone. Methylated 
cytosines are indicated by black boxes, grey boxes mark unmethylated C38. 
 
In the experiment that showed complete tRNAAsp methylation upon pmt1+-
overexpression in EMM medium, we also found tRNAGlu to be methylated to about 
25 % (Figure 15). This tRNA was also shown to be a Pmt1 target when recombinant 
Pmt1 methylated in vitro transcribed tRNAGlu (Figure 12). Thus, we wanted to 
investigate, whether tRNAGlu is also methylated when cells are cultured in YPD 
medium, because the high methylation level of tRNAAsp indicates activity of Pmt1 
under these conditions. We performed RNA bisulfite sequencing for tRNAGlu using 
RNA extracted from wild-type cells cultured in YPD medium. Interestingly, we were 
unable to detect methylation of tRNAGlu at position C38 (Figure 18). The methylation 
at position C48 verified the results we detected for the methylation of position C38. 
This result suggests a differential activity of Pmt1 under the different culture 
conditions, because despite the similar tRNAAsp methylation in RNA extracted from 
cells cultured in YPD or with the pmt1+-overexpression plasmid from EMM medium, 
the tRNAGlu methylation level differed significantly in these two conditions. 
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Figure 18: tRNAGlu is not methylated in S. pombe cells cultured in YPD. 
Bisulfite analysis was performed for tRNAGlu from wild type cells cultured in YPD medium. Each 
column represents a cytosine of tRNAAsp, each line represents an individual clone. Methylated 
cytosines are indicated by black boxes, grey boxes mark unmethylated C38. 
 
We sought to verify all these results from the bisulfite sequencing using the in vitro 
methylation assay. We used recombinant Pmt1 to methylate RNA from wild-type and 
pmt1Δ cells that were cultured in S. pombe complete medium (YES) or S. cerevisiae 
complete medium (YPD). In agreement with the RNA bisulfite sequencing results, we 
found no difference in the methylation level between wild-type and pmt1Δ cells that 
were grown in YES medium (Figure 19). However, wild-type RNA that was extracted 
from cells cultured in YPD showed a decreased methylation signal compared to the 
deletion strain cultured in the same medium. This further supported the results from 
the bisulfite sequencing, where we found almost 100 % tRNAAsp methylation in the 
wild-type strain cultured in YPD. This led us to ask which component of the medium 
was responsible for tRNA methylation in YPD. 
 
Table 9: Composition of YPD and YES medium 
 YPD YES 
Supplements none 250 mg/L 
Glucose 2 % 3 % 
Yeast extract 1 % 0,5 % 
Peptone 2 % none 
 
A comparison of the composition of the two media (Table 9) showed that the amount 
of the components that were used in both media were variable. While both media 
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contained glucose and yeast extract, the amounts of both components differed. YES 
medium contained 3 % glucose and 0.5 % yeast extract, whereas YPD has 2 % 
glucose and 1 % yeast extract. Furthermore, YES medium is supplemented with 
adenine, leucine, histidine, lysine and uracil (250 mg/L each) and YPD contains 2 % 
peptone and has none of the defined supplements. To test which ingredient was 
responsible for the altering methylation levels of cellular RNA, we created media that 
had the amount of one component adapted to the respective other medium. This led 
us to a total amount of 10 different media, including the two standard media YES and 
YPD. We then analyzed RNA extracted from wild-type and pmt1Δ cells cultured in all 
of the resulting media in the methylation assay with recombinant Pmt1.  
 
                  
Figure 19: Peptone induces tRNA methylation. 
Total RNA extracts from wild type and pmt1Δ cells, cultured in YES or YPD medium either with or 
without peptone, were analyzed using in vitro methylation by Pmt1 (3 µM). The samples were 
separated using urea-PAGE and methylation signals were detected by autoradiography. 
 
We found that the level of tRNA methylation by Pmt1 was not affected by the amount 
of glucose, the percentage of yeast extract or the presence of supplements (data not 
shown). However, the addition of peptone to YES medium resulted in an increased in 
vivo methylation of tRNA, which was detected as a reduced methylation signal in the 
in vitro methylation assay (Figure 19). Accordingly, when peptone was omitted from 
YPD medium, the in vivo methylation of the wild type cells was reduced to the level of 
the pmt1Δ strain, as indicated by the strong methylation signal in the in vitro assay.  
Peptone is a mixture of nutrients that is generated by peptic digestion of animal 
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cellular components. It is used as a nitrogen source for the yeast cells, but the exact 
nitrogen source is not defined. Our results indicated that one or more components of 
peptone increase Pmt1 activity and induce in vivo tRNA methylation.  
We hypothesized that perhaps the nitrogen in peptone was the factor activating 
Pmt1. Since complete media contain the undefined components yeast extract and 
peptone, we cannot alter the amount of nitrogen in these media without altering many 
other components. Individual media components can only be varied in completely 
defined media. For S. pombe, such a fully synthetic medium is the Edinburgh Minimal 
Medium (EMM). The only nitrogen source in this medium is ammonium chloride 
(NH4Cl). To test our hypothesis, we therefore changed the normal 0.5 % NH4Cl to 
0 % and to 2.5 %. If Pmt1 was activated by increasing amounts of nitrogen, the tRNA 
methylation should increase with increasing amounts of NH4Cl.  
                                   
Figure 20: tRNA methylation is inhibited by ammonium chloride 
RNA was extracted from pmt1Δ cells carrying a control vector or a pmt1+-overexpression vector 
cultured in minimal medium containing varying amounts of NH4Cl (0%, 0.5% and 2.5%). The RNA was 
used for in vitro methylation by Pmt1. The samples were separated using urea-PAGE and methylation 
signals were detected by autoradiography.  
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activation and subsequent tRNA methylation by increased amounts of ammonium 
chloride would be indicated by a decreased methylation signal for the RNA extracted 
from cells grown in 2.5 % NH4Cl. Contrary to our expectations, the in vitro 
methylation signal increased with increasing amounts of ammonium chloride (Figure 
20). Unfortunately, the RNA extracted from cells that were cultured in medium 
containing 0 % NH4Cl had a very low concentration and despite the equalization of 
the used amounts of RNA the EtBr staining showed a significantly lower amount of 
RNA for this sample. However, the results for the samples from cells cultured in 
0.5 % and 2.5 % NH4Cl indicated that in vivo tRNA methylation was reduced upon 
increasing NH4Cl in the medium. Reduced tRNA methylation would originate from a 
reduced activity of Pmt1. 
 
5.6 tRNA methylation by Pmt1 depended on the kinase Sck2 
To gain further insight into the nutrient dependence of the tRNA methylation by Pmt1, 
we hypothesized that the TOR signaling pathway might be involved in activating 
Pmt1 upon changes in nutrient availability. The mammalian TOR pathway is well 
known to sense the nutritional status of cells. By phosphorylation of various target 
proteins, like the serine/threonine kinase S6K that phosphorylates the ribosomal 
protein S6, the mTOR complex 1 (mTORC1) signals to global mRNA translation, 
ribosome synthesis, autophagy and aging mechanisms (Sharp and Richardson 
2011). These mechanisms help the cells to adapt to dietary restriction and are 
involved in the regulation of lifespan and healthspan.  
In S. pombe, there are two homologs of TOR annotated in the genome, tor1+ and 
tor2+. Tor2+ is an essential gene that is required for normal growth (Kim et al. 2010), 
whereas tor1+ is required only during cell proliferation under stress conditions and for 
sexual differentiation under nitrogen starvation (Weisman and Choder 2001). Fission 
yeast also carries a homolog of the S6 kinase called Sck2. Sck2 is a non-essential 
gene that is involved in the regulation of life span, since sck2Δ cells display an 
elongated lifespan (Roux et al. 2006). The same extended lifespan has been 
demonstrated for pka1Δ cells. Pka1 is a kinase that is involved in the glucose-
sensing pathway of S. pombe (Byrne and Hoffman 1993). 
In a first approach, we investigated the two downstream effector kinases Sck2 
(probably downstream of TOR) and Pka1 (downstream of the glucose receptor Git3). 
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To test whether any of these two kinases are responsible for the activation of Pmt1, 
we tested whether the deletion of sck2+ or pka1+ had an influence on the tRNA 
methylation level. We first hypothesized that RNA methylation by Pmt1 might be 
inhibited by one of the nutrient sensing pathways in S. pombe standard complete 
medium (YES). If those pathways would signal a sufficient nutritional status that does 
not require tRNA methylation, then the tRNA methylation should increase upon 
deletion of the factor transducing the signal. This would mean that the nutrient 
signaling pathways under abundant nutrient condition would inhibit Pmt1 activity. 
This would result in increased Pmt1-dependent RNA methylation when the signaling 
pathways were interrupted. As a result, the methylation signal after the in vitro 
methylation reaction should be reduced. To test this hypothesis, we used RNA 
extracted from pka1Δ and sck2Δ strains that were cultured in S. pombe complete 
medium for in vitro methylation by Pmt1. However, we found no change in the 
methylation level upon deletion of either pka1+ or sck2+ (Figure 21). The detected 
methylation signals were as strong in the two deletion strains as in the wild type, 
which suggests that there was no Pmt1-dependent RNA methylation in the pka1Δ 
and the sck2Δ strain. 
                                         
Figure 21: tRNA methylation in YES medium is not affected by deletion of pka1+ or sck2+. 
RNA was extracted from wild type, pka1Δ or sck2Δ cells cultured in S. pombe complete medium YES. 
The RNA was subjected to in vitro methylation by Pmt1. The samples were separated using urea-
PAGE and methylation signals were detected by autoradiography. 
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Next, we asked whether those nutrient-sensing pathways might activate Pmt1 in YPD 
medium, which was opposite to our first hyposthesis. Therefore, we performed in 
vitro methylation analysis of RNA extracted from sck2Δ, tor1Δ (Figure 22A) and 
pka1Δ (Figure 22B) cells that were cultured in YPD medium. A strain deleted for 
sck1+, a kinase unrelated to TOR signaling or the glucose-sensing pathway, was 
used to compare the effect on different signaling pathways. In YPD medium, tRNAAsp 
is methylated (see above) and an inhibition of Pmt1 should result in reduced 
methylation levels in vivo. This can be detected by observing increased in vitro 
methylation by recombinant Pmt1. The data show weak methylation signals for RNA 
from sck1Δ, tor1Δ (Figure 22A) and pka1Δ (Figure 22B), which suggested high in 
vivo methylation in these strains, as is also the case in the wild type cells. Therefore, 
this indicated that those deletions had no effect on tRNA methylation. In contrast, in 
cells deleted for sck2+, the in vivo methylation was reduced, as indicated by the 
increased in vitro methylation signal (Figure 22A). This suggested that Sck2 is at 
least partially required for Pmt1-dependent RNA methylation in YPD medium and led 
us to the assumption that Sck2 either directly or indirectly activated Pmt1. 
      
Figure 22: tRNA methylation by Pmt1 is activated by sck2+. 
(A) Total RNA extracts from sck1Δ, sck2Δ or tor1Δ cells cultured in S. cerevisiae complete medium 
YPD were used for in vitro methylation by Pmt1. The samples were separated using urea-PAGE and 
methylation signals were detected by autoradiography. (B) Total RNA extracts from pka1Δ or sck2Δ 
cells or double deletions of those genes with pmt1Δ, cultured in S. cerevisiae complete medium YPD, 
were analyzed using in vitro methylation by Pmt1. The samples were separated using urea-PAGE and 
methylation signals were detected by autoradiography. 
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When pmt1+ was additionally deleted in the pka1Δ or sck2Δ background, the in vitro 
methylation signal was increased. This further validates the dependency of the RNA 
methylation on pmt1+. The in vivo methylation level in the sck2Δ single deletion is 
reduced compared to wild type cells, but it is not as low as in an sck2Δ pmt1Δ double 
deletion strain. These results support an involvement of Sck2 in the regulation of 
Pmt1-dependent tRNA methylation. 
                                  
Figure 23: Deletion of sck2+ inhibits Pmt1 activity upon pmt1+-overexpression. 
Total RNA extracts from pka1Δ pmt1Δ or sck2Δ pmt1Δ cells containing either a control vector or a 
pmt1+-overexpression vector, cultured in S. cerevisiae complete medium YPD, were used for in vitro 
methylation by Pmt1. The samples were separated using urea-PAGE and methylation signals were 
detected by autoradiography. 
 
We also investigated the effect of the deletion of pka1+ and sck2+ in a situation with 
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almost undetectable. As in the wild-type, this suggested complete tRNAAsp 
methylation upon pmt1+-overexpression. These results indicated that Sck2 was 
required for full Pmt1 activity, even upon elevated Pmt1 levels. The increased 
amount of Pmt1 protein could not compensate for the reduced activity that was 
dependent on sck2+. Furthermore, this result supported the assumptions drawn from 
the results obtained from sck2Δ cells cultured in YPD medium. Even upon 
overexpression of pmt1+, there was a detectable signal after the in vitro methylation 
reaction. This could be explained by incomplete methylation of Pmt1 substrates in 
vivo. This supports the hypothesis that Pmt1 activity is inhibited upon sck2+ deletion. 
 
                            
Figure 24: Rapamycin treatment causes loss of methylation signal. 
Total RNA extracts from wild type or pmt1Δ cells containing a control vector, cultured in S. pombe 
minimal medium EMM, were used for in vitro methylation. The cells were treated with 0 nM, 200 nM or 
400 nM rapamycin. The samples were separated using urea-PAGE and methylation signals were 
detected by autoradiography. 
 
Next, we asked whether the TOR (target of rapamycin) signaling pathway could be 
involved in the regulation of Pmt1, although the deletion of tor1+ had no effect on 
Pmt1-dependent tRNA methylation. Since there are two homologs of TOR present in 
S. pombe, we hypothesized that maybe Tor2 signals to Sck2. To investigate the 
effect of Tor2 on Pmt1-dependent RNA methylation, we could not use a tor2Δ strain, 
because the deletion of tor2+ is lethal for fission yeast cells (Kim et al. 2010), and we 
do not have a tor2 mutant allele at our disposal. Therefore, we sought to inhibit TOR 
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pmt1Δ cells with increasing amounts of rapamycin. The RNA isolated from these 
cells was then used for in vitro methylation. Significantly, we observed a decreasing 
methylation signal for the wild-type cells with increasing amounts of rapamycin 
(Figure 24), which was opposing to our expectations and indicated that TOR 
inhibition increased in vivo RNA methylation by Pmt1. We also treated pmt1Δ cells 
with rapamycin, and surprisingly we also observed a decrease in the methylation 
signal upon rapamycin treatment, which is counterintuitive, because it would indicate 
increased in vivo methylation in the absence of Pmt1. This indicated that the 
observed reduction of the methylation signal in the wild type could not be attributed to 
increased in vivo tRNA methylation caused by elevated Pmt1 activity. A decrease of 
the in vitro methylation signal in the pmt1Δ strain could be explained in three ways. 
The first one would be that another methyltransferase upon rapamycin treatment 
would methylate in vivo the targets of the recombinant enzyme. The second 
explanation is the degradation of the unmethylated Pmt1 substrates upon treatment 
with rapamycin. The third reason could be reduced tRNA transcription upon 
rapamycin treatment (see discussion).  
 
5.7 Pmt1 influenced the chronological lifespan of yeast cells 
Factors involved in nutrient sensing are known to have an influence on the maximal 
lifespan in yeast cells (Kaeberlein 2010). Impaired TOR signaling leads to an 
increased lifespan in S. cerevisiae (Fontana et al. 2010). Studies in S. pombe imply a 
similar lifespan regulation in the fission yeast. Reduced TOR signaling can be 
achieved either by addition of rapamycin to the yeast cultures or by deletion of 
downstream targets of the TOR complex. Accordingly, sck2Δ cells have been shown 
to display an elongated lifespan (Roux et al. 2006; Chen and Runge 2009), as is the 
case for the S. cerevisiae homolog of Sck2, Sch9 (Fabrizio et al. 2001). This, 
together with our observation of reduced tRNA methylation in sck2Δ cells, raised the 
question whether pmt1+, and therefore also tRNA methylation, are involved in the 
regulation of lifespan in S. pombe cells. 
Therefore, we investigated the influence of pmt1+ on chronological lifespan of 
S. pombe cells. If the lifespan extension of sck2Δ cells was at least partially mediated 
by impaired activation of Pmt1, we would expect pmt1Δ cells to have an elongated 
lifespan compared to wild-type cells. To test this hypothesis, we cultured wild-type 
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and pmt1Δ cells carrying either a control vector or a pmt1+-overexpression vector in 
minimal medium. The viability of the cells was measured using the CFU (colony 
forming units) method. At regular intervals, samples from the aged cultures were 
plated onto full medium plates, and the number of cells that were able to form 
colonies was counted after 3 days of incubation at 30 °C.  
As a result, we found pmt1Δ cells to display an elongated lifespan compared to 
strains containing the pmt1+ gene, independent of the gene’s expression level 
(Figure 25). This indicated that Pmt1-dependent tRNA methylation decreased 
chronological lifespan of the fission yeast cells. Interestingly, we found no significant 
difference between cells with 100 % tRNAAsp methylation (wt or pmt1Δ + pmt1+-OE) 
and cells with only about 25 % tRNAAsp methylation (wt + control vector). Taken 
together, these results suggest that tRNA methylation via Pmt1 shortens 
chronological lifespan in S. pombe and that this pathway might be one component of 
sck2Δ-induced lifespan extension. 
          
Figure 25: Deletion of pmt1+ increases chronological lifespan in S. pombe cells in EMM. 
Wild type and pmt1Δ cells carrying either a control vector or a pmt1+-overexpression vector were 
cultured in S. pombe minimal medium EMM for several weeks. Viability of the yeast cells was 
measured by counting colony-forming units at regular intervals. 
 
A change of the culture medium could have strong impact on tRNA methylation 
levels, as was seen in the RNA bisulfite and in vitro methylation experiments. 
Therefore we asked, whether a change of the medium also had an effect on the 
lifespan of the yeast cells. We cultured wild-type and pmt1Δ cells in YPD medium 
and measured cell viability using the CFU method. We showed previously that 
tRNAAsp was methylated to almost 100 % in this medium, which is the same amount 
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of tRNAAsp methylation as in EMM medium upon pmt1+-overexpression. This meant 
that the tRNA methylation levels were comparable with the previous aging 
experiment. Thus, we expected the wild-type cells to age more rapidly than the 
pmt1Δ cells. However, the data revealed an increased lifespan of the wild-type 
compared to the pmt1Δ strain in YPD medium (Figure 26A). We also performed a 
chronological lifespan experiment and did not count colony-forming units, but instead 
plated serial dilutions of the aged cultures onto full medium plates. The result of this 
second aging experiment was comparable to the previous one. The wild-type 
cultures contained more living cells after prolonged incubation than the pmt1Δ 
cultures (Figure 26B). The reason why this result seemed to be contrary to the 
results obtained in minimal medium remained enigmatic (see discussion). 
     
Figure 26: Deletion of pmt1+ decreases chronological lifespan of S. pombe cultured in YPD. 
Wild type and pmt1Δ cells were cultured in S. cerevisiae complete medium YPD for several weeks. 
Viability of the yeast cells was measured by counting colony forming units (A) or by plating serial 
dilutions onto full medium plates (B) at regular intervals. 
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In our previous experiments, we observed strong differences in Pmt1-dependent 
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0,1
1
10
100
0 5 10 15 20 25
wt 
pmt1¨
days
C
FU
/m
L 
in
 %
wt
SPW¨
0 days 14 days 18 days 35 days
A
B
Results 
 72 
conditions. Besides inhibition or activation of the catalytic activity of the enzyme, 
increasing or decreasing protein levels could be a potential cause for variations in 
Pmt1 activity. Therefore, we analyzed gene expression and protein level to gain 
insight into the abundance of Pmt1. 
To measure the expression of pmt1+ on mRNA level, we used RT-PCR followed by 
qPCR. In this experiment, we wanted to investigate the differential expression of 
pmt1+ when it was transcribed either from an overexpression vector containing the 
nmt1-promoter, from a vector containing the endogenous pmt1-promoter or from the 
genomic locus. Furthermore, we asked whether the endogenous expression of pmt1+ 
was altered when the yeast cells were cultured in YES or YPD medium. 
 
 
Figure 27: Levels of pmt1+ upon expression from its native promoter or the nmt1 promoter 
(A) pmt1+ expression relative to act1+ was measured by quantitative RT-PCR. RNA was extracted 
from a pmt1∆ strain carrying either pmt1+ expressed from the nmt1 promoter (pAE1890) or from the 
native pmt1 promoter (pAE1891). Furthermore, RNA was extracted from a wild-type strain (wt, AEP1) 
grown either in YES or in YPD medium. The inset graph shows the same data as in the large graph, 
but on a different scale and without expression from the nmt1 promoter, for better representation of 
the low expression range. The experiment was performed by and the figure is courtesy of Karolin 
Nicklasch. (B) Pmt1 protein levels were indistinguishable in YES and YPD medium. TAP-tagged Pmt1 
(AEP10) was detected using PAP antibody (peroxidase anti-peroxidase, Sigma). Nuclear pore 
complex protein (Nup) served as a loading control and was detected using Mab414 antibody 
(Covance). 
 
We observed a 100-fold increase of the pmt1+ mRNA level when the gene was 
expressed from a vector with the nmt1 promoter compared to expression from a 
vector with the endogenous promoter (Figure 27A). The expression from the vector 
with the endogenous promoter was still 10-fold higher than the genomic expression. 
Significantly, the genomic expression level of pmt1+ was not altered between the two 
different complete media YES and YPD. From this experiment, we concluded that the 
increased tRNA methylation levels in cells carrying the pmt1+-overexpression vector 
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compared to cells expressing genomic pmt1+ in the same medium could be attributed 
to the strongly increased levels of pmt1+ expression. Combined with our observations 
on tRNA methylation levels, these results indicate that even the low amounts of 
genomically expressed pmt1+ are sufficient to methylate tRNAAsp to 100% (wt in 
YPD, Figure 17) or at least partially (wt + control vector in EMM, Figure 13) in cells 
that do not carry a copy of pmt1+ on a plasmid. 
Because the observed pmt1+ mRNA levels were very low, we next asked whether the 
protein level of Pmt1 was detectable and whether it was altered in the two different 
complete media. Therefore, we sought to investigate, if we could detect protein levels 
in the yeast cells that expressed pmt1+ from the genomic locus by immunoblotting. 
Western blot analysis of genomically expressed TAP-tagged Pmt1 revealed a 
detectable amount of protein in the extracts from cells cultured in YES medium 
(Figure 27B). Significantly, the protein level was not altered when the cells were 
cultured in YPD medium. The protein level of nuclear pore complex proteins served 
as a loading control. These results indicated that the differences in the Pmt1-
dependent tRNA methylation in YES and YPD medium were not caused by an 
increase in the amount of Pmt1 protein upon growth in YPD medium. 
 
5.9 Overexpressed Pmt1 localized to the cytoplasm and the 
nucleus 
To determine the subcellular localization of Pmt1, we wanted to visualize the protein 
using the green-fluorescent protein (GFP) tag. In a first approach, we integrated a 
GFP tag into the genomic pmt1+ locus. The cells were cultured in YES or YPD 
medium and the protein localization was analyzed by fluorescence microscopy. As a 
result, we were unable to detect the localization of Pmt1 using GFP-tagged genomic 
Pmt1 (data not shown). The autofluorescence of the S. pombe cells was more 
prominent than a possible specific GFP signal. Taking into account the low 
expression level that we determined previously (see above), this could be explained 
by the low amount of protein in the cells.  
To increase the amount of protein within the yeast cells, we created an 
overexpression vector containing the intron-less pmt1+ sequence under the control of 
the nmt1-promoter in front of a GFP tag. The tagged protein was expressed in the 
S. pombe cells and visualized using fluorescence microscopy (Figure 28). The 
Results 
 74 
overexpressed gene product Pmt1-GFP could be detected in the whole cell, in the 
nucleus as well as in the cytoplasm. This observation was in agreement with 
previous findings (Matsuyama et al. 2006) and was also consistent with a tRNA 
methyltransferase activity of Pmt1. 
    
Figure 28: Localization of GFP-tagged Pmt1 
Pmt1-GFP was expressed from the overexpression vector pSGP572a-pmt1 in S. pombe cells cultured 
in minimal medium (EMM) and the protein was visualized using fluorescence microscopy. Cells 
expressing Pmt1 from the overexpression vector REP4X-pmt1 served as a negative control (Pmt1-
untagged). 
 
5.10 Endogenous Pmt1 was purified without associated factors 
The previous experiment demonstrated that the amount of Pmt1 protein was not 
altered in YES and YPD medium, yet the activity of Pmt1 varied significantly, 
because we detected 0 % tRNAAsp methylation in a wild-type strain cultured in YES 
medium and 100 % methylation when this strain was cultured in YPD medium. We 
hypothesized that Pmt1 might work in a complex with other proteins and might be 
regulated in this context. To test this hypothesis, we sought to purify a putative Pmt1-
containing complex from S. pombe cells. 
An established method to purify endogenous protein from yeast cells is the Tandem-
Affinity Purification (TAP (Rigaut et al. 1999)). The native conditions of this 
purification method allow for copurification of associated proteins that subsequently 
can be identified using mass spectrometry. The TAP method was therefore used to 
purify TAP-tagged Pmt1 from S. pombe cells cultured in YES medium. We 
successfully purified Pmt1 by the TAP purification, but the amount of purified protein 
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was comparatively low, since CBP-tagged Pmt1 was only detectable using silver 
staining to visualize Pmt1 at the expected size of approximately 43 kDa (Figure 29). 
There were no obvious additional prominent bands in the Pmt1 purification. All bands 
other than Pmt1-CBP were also present in a parallel purification using a strain 
lacking Pmt1-TAP. This result suggested that either the amount of associated factors 
was below the detection limit, that Pmt1 may not be a member of a large protein 
complex, or that interactions with other proteins may be temporary. Considering the 
different activity of Pmt1 in the different complete media, it would also be possible 
that a complex formation was inhibited in YES medium. 
                      
Figure 29: Tandem-Affinity-Purification of Pmt1 
TAP-tagged Pmt1 was purified from S. pombe cells (AEP10). The eluate from a purification from a 6L 
culture in YES medium was separated by SDS-PAGE and silver stained. A protein band that migrated 
at approximately 43 kDa was identified as Pmt1-CBP, because it was not present in the wild type 
strain. 
 
5.11 A synthetic genetic array to identify factors that are 
synthetically lethal with pmt1Δ 
Synthetic lethality is a form of negative genetic interaction that occurs if two genes 
are deleted or mutated that work in parallel pathways. If only one of the two genes is 
deleted, the cells are viable, since the parallel pathway compensates the effect of the 
missing gene product. If the second gene additionally is deleted, the cells become 
sick or are not even viable at all. Since little is known about the function of Pmt1 in 
S. pombe, we reasoned that we could use a synthetic lethality screen to identify 
factors that function in a pathway parallel to Pmt1.  
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Figure 30: The synthetic genetic array identified candidate genes for synthetic genetic 
interactions 
A pmt1Δ strain (AEP37) was crossed with strains from a deletion library on SPAS medium. Selection 
for haploid single mutants on YES+GC medium and subsequent selection for haploid double mutants 
on YES+GNC medium identified genes that affect cell growth only upon pmt1+-deletion. The figure 
shows the selection plates of candidate genes. Each spot on the plates represents an individual cross. 
The first number of each label represents the number of the 96 well plate of the deletion library that 
was used for the cross. The capital letter gives the lane and the second number gives the column on 
that 96-well plate that identifies the candidate gene. 
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Among others, one way to identify synthetic lethal interactions is a synthetic genetic 
array (SGA). A synthetic genetic array is based on a library of deletions of all 
nonessential genes in an organism, in this case S. pombe. In this assay, a pmt1Δ 
strain was crossed with every strain from the deletion library. The selection 
procedure of the assay allowed us in a first step to isolate haploid cells with the 
deletion from the library, and in a second step, to isolate double mutants that carried 
both the deletion from the library and the pmt1+ deletion. If there were sporulation 
products with the deletion from the library, but no viable double deletions, then we 
would have identified a gene that is probably synthetic lethal with the pmt1+ deletion.  
 
 
Figure 31: Validation of primary candidates identifies 3 secondary candidates 
The procedure of the SGA was repeated with the primary candidate genes. The figure shows the 
selection plates of candidate genes. The spots in each lane of the plates represent independent 
crosses of the same candidate deletion with the pmt1Δ strain. The lanes are labeled with the name of 
the deleted gene according to the Bioneer Deletion Library Version 2.0. Boxes mark genes that show 
a reduced growth on YES+GNC compared to YES+GC. The boxes are color-coded: blue = genes 
linked to pmt1+, red = secondary candidates. 
 
We screened the Bioneer Deletion Library, which includes approximately 3000 gene 
deletions for deletions that are lethal in combination with pmt1Δ. The selection 
procedure was performed according to the established protocol (see material and 
methods). We were thus able to identify 28 primary candidate gene deletions 
(Figure 30). To validate the candidates from the initial screen, we repeated the 
screening procedure with these candidate gene deletions. In this experiment, we 
performed the selection procedure for each candidate six times in parallel. Seven of 
the initial 28 candidates (SPBC21B10.08c, SPBC2D10.16, rps402, yox1, 
SPAC17A2.02c, wdr21, ubp11) showed an impaired growth upon selection for 
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haploid double mutants in this validation experiment (Figure 31), whereas the other 
candidate deletions produced viable double mutants with the pmt1Δ strain. 
To validate that a candidate gene was synthetic lethal with our deletion of interest, 
we first had to check whether the two genes are linked. This was important, because 
the whole array was based on crossovers between the sister chromatids when cells 
undergo meiosis. These crossovers can produce spores with both deletions. If two 
genes were located at some distance on the same chromosome, the crossover could 
happen between them. However, if the two genes were located in very close 
proximity, then the probability for a crossover between the two genes was low. In 
such a case, the two genes would be linked, and this would impede the development 
of double mutants. In this case the lack of double mutants would not show a synthetic 
lethality of the two genes, but linkage to each other. 
 
Table 10: Localization of candidate genes 
Gene Chromosome Position on chromosome II 
Distance to 
pmt1+ in bp 
Distance to 
pmt1+ in cM 
pmt1 2 1674066-1675102 - - 
SPBC21B10.08c 2 1655946-1656777 17289 2.9 
SPBC2D10.16 2 2996452-2996879 1321350 220 
rps402 2 1651022-1651810 22256 3.7 
yox1 2 1648235-1648840 25226 4.2 
SPCC162.11c 3 - - - 
wdr21 1 - - - 
ubp11 2 1676524-1677576 1422 0.2 
 
To evaluate the location of the candidate genes that are located on the same 
chromosome as pmt1+, the distance of the two gene loci is calculated by basepairs 
and centimorgan (cM). A centimorgan gives an estimate about the probability of a 
crossover between two genes; 1 cM represents a probability of 1% per meiosis. In 
S. pombe, 1 cM is approximately 6 kbp of genomic DNA (Sunnerhagen et al. 1990). 
Analysis of the gene location revealed that four of the seven candidate genes 
(SPBC21B10.08c, rps402, yox1, ubp11) are located close to the pmt1+ gene locus 
with distances between 0.2 and 4.2 cM (Table 10) and are therefore linked to pmt1+. 
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A synthetic lethal interaction of these genes with pmt1+ cannot be identified with the 
applied assay. 
The other three candidate genes could display synthetic lethal interactions with 
pmt1Δ and were further validated. A classical genetic cross of two strains with each 
deletion and tetrad dissection should be used to further analyze the remaining three 
secondary candidates, wdr21, SPCC162.11c and SPBC2D10.16. This approach was 
used as an independent method to show synthetic lethal interactions. Tetrad 
dissection should yield single mutants for each of the two gene deletions, wild-type 
spores and double mutants. The double mutants should not be viable, if the 
combination of the two tested gene deletions is synthetic lethal, and therefore they 
should not develop on complete medium (YES) plates.  
        
 
Figure 32: Growth of spores obtained from cross of pmt1Δ with a secondary candidate gene 
(A) A pmt1Δ strain (AEP37) was crossed with a strain deleted for a secondary candidate gene of the 
SGA (SPCC162.11cΔ). After sporulation tetrads were dissected and the spores were analyzed for 
their ability to grow on standard complete medium (YES). Six spores were analyzed for each genotype 
(1-6). (B) Like (A), but for the deletion of the candidate gene SPBC2D10.16. Growth of 3 segregants 
for each genotype is displayed. 
 
For unknown reasons, we were unable to obtain sporulation products from the cross 
of pmt1Δ and wdr21Δ. Crosses of the other two gene deletions with a pmt1Δ strain 
resulted in mating and sporulation, which allowed for tetrad dissection. All four spores 
of a tetrad that developed after the cross of the deletions of the two putative synthetic 
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lethal interaction partners were analyzed for their ability to grow on S. pombe 
complete medium plates (YES).  
Spores that carried both deletions of synthetic lethal interaction partners should be 
unable to grow on YES medium plates. However, despite the results from the 
synthetic genetic array, we were able to obtain double mutants from the crosses, and 
we were unable to detect a growth defect on YES medium for these double mutants 
(Figure 32). The double mutants did not grow significantly worse than the single 
mutant of the candidate gene. Thus, we could not verify synthetic interactions with 
pmt1+ that were identified using the Synthetic Genetic Array (see discussion). 
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6 Discussion  
Schizosaccharomyces pombe does not contain any detectable methylation in its 
genomic DNA (Antequera et al. 1984). Despite this notion, a putative DNA 
methyltransferase called Pmt1 is annotated in the genome of the fission yeast 
(Wilkinson et al. 1995). Sequence comparisons revealed a membership to the Dnmt2 
family of DNA methyltransferases (Yoder and Bestor 1998) that were shown to have 
only weak DNA methyltransferase activity, but to have a robust and specific tRNA 
methyltransferase activity (Goll et al. 2006). Pmt1 possesses no DNA 
methyltransferase activity, which was attributed to a proline-to-serine mutation in 
DNA methyltransferase motif IV next to the catalytic cysteine (Wilkinson et al. 1995; 
Pinarbasi et al. 1996). 
 
6.1 The proline-to-serine mutation in the Pmt1 sequence does 
not inactivate the enzyme 
In this study, we demonstrated that Pmt1 is a tRNA methyltransferase that modified 
the cytosine at position 38 of tRNAAsp. This was expected for a Dnmt2 homolog and 
showed that Pmt1 is an active enzyme, despite the deviation from the consensus 
sequence of Dnmt2 enzymes that was claimed to be responsible for the absence of 
detectable methyltransferase activity (Wilkinson et al. 1995; Pinarbasi et al. 1996). 
The proline residue that is found next to the catalytic cysteine in motif IV of other 
Dnmt2 enzymes is a special amino acid, because its cyclic structure makes the side 
chain less flexible and introduces a different angle into the peptide chain than other 
amino acids. This is associated with a turn in the chain and explains why proline 
disrupts α-helices and β-sheets and is often found in loops. This is also the reason 
why proline is often solvent-exposed, although it is a hydrophobic amino acid with a 
completely aliphatic side chain. In Dnmt2 enzymes, this proline residue of motif IV is 
located in a loop right next to the catalytic cysteine and positions the catalytic residue 
next to a turn (Dong et al. 2001). If a serine residue replaces this proline residue, the 
loop will gain some flexibility. However, there is a second proline in motif IV (PPCQ in 
Dnmt2, PSCQ in Pmt1), which would prevent a complete disruption of the turn, and 
the motif is located in a loop, which naturally is a flexible region of a protein and 
might reduce the importance of the angle of a turn at this position of the peptide 
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chain. Taken together, these observations would indicate that a proline-to-serine 
mutation at this position of Dnmt2 proteins is not destined to disrupt the activity of the 
enzyme, as was previously assumed (Wilkinson et al. 1995). Our results demonstrate 
catalytic activity of the “mutant” protein Pmt1 and support the considerations on a 
proline-to-serine mutation at this position. 
We were also able to identify a further target for methylation at C38 by Pmt1. This 
second substrate, tRNAGlu, was methylated to a lesser extent than the major target, 
tRNAAsp. The comparison of the sequences of these two tRNAs revealed that 
tRNAAsp matches a proposed target recognition pattern (Mark Helm, unpublished 
data), but the tRNAGlu sequence matches only at three out of four sites of this 
pattern. If these four bases (Table 8) were required for target recognition by Dnmt2 
proteins, this explains the lower activity of Pmt1 on tRNAGlu, because not all of the 
necessary recognition sites were present. This could result in a more flexible 
association of the substrate to the catalytic pocket, which could set the substrate free 
before the methylation reaction is completed. Another reason for a reduced catalytic 
activity could be the orientation of the tRNA inside the enzyme. If the mismatch in the 
target recognition pattern causes a repositioning of the substrate, this would impede 
the contact of the catalytic amino acids to the substrate, leading to impaired substrate 
methylation. 
 
6.2 Is Pmt1 activity specific for tRNAAsp and tRNAGlu? 
In this study, we present evidence for the tRNA methyltransferase activity of Pmt1 on 
tRNAAsp and tRNAGlu of the fission yeast S. pombe. We did not identify other targets 
for the methylation by Pmt1. However, could additional substrates for Pmt1-
dependent methylation exist? We identified tRNAGlu as a substrate by sequence 
specific RNA bisulfite sequencing. In this experiment, we also investigated other 
tRNAs that partially match the recognition pattern of Dnmt2 enzymes. For technical 
reasons, we were unable to obtain data for these additional tRNAs. Therefore, it is 
possible that one of these tRNAs might be a target for Pmt1. 
The results obtained from the methylation assay displayed a methylation signal at the 
size of tRNAs. We cannot exclude that in the bulk of RNAs in this band of the gel 
there are additional RNA species of similar size present. These RNAs could be Pmt1 
targets, but they could not be identified with the assay applied here. Putative target 
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RNAs would have to exhibit a tertiary structure that is similar to the L-shaped 3D-
structure of tRNAs, because this structure is probably required for target recognition 
by Dnmt2 enzymes. Interesting candidates for additional methylation targets could be 
centromeric RNAs or other transcripts that could be used by the RNAi machinery. 
Such targets might imply a function for Pmt1 in gene silencing. 
Furthermore, RNAs of sizes that differ from the size of a tRNA could also be targets 
of Pmt1-dependent methylation. These possibly larger targets should display a local 
structure that is similar to the tRNA structure. They could be methylated in the in vitro 
reaction, but not be detected, because they might be less abundant and their 
methylation signal therefore would be below the detection limit of the methylation 
assay.  
 
6.3 The impact of C38 methylation on tRNA function 
We have demonstrated that Pmt1 is able to methylate tRNAs in the anticodon loop. 
What influence could this modification of the tRNA have on its function? The 
methylation at position 38 of the anticodon loop can have an influence on the tertiary 
structure of tRNA molecules. Nucleotide modification in RNAs often leads to 
structural and metabolic stabilization (Helm 2006). Furthermore, m5C residues can 
be important for appropriate Mg2+ binding and thus can induce conformational 
changes of the whole anticodon loop (Chen et al. 1993). This could also be true for 
the C38 methylation by Pmt1. Structural stabilization of target RNAs could be a 
reason for the strong conservation of Dnmt2 enzymes, but there are probably 
additional benefits from this methylation, because single tRNA modifications only 
slightly influence tRNA structure (Derrick and Horowitz 1993; Vermeulen et al. 2005).  
One of these benefits could be the protection from the rapid tRNA decay (RTD) 
pathway. This pathway degrades m5C-deficient tRNA molecules in S. cerevisiae 
when the methyltransferases for 5-methylcytosine and 7-methylguanosine are absent 
(Alexandrov et al. 2006). This pathway seems to be rather specific for tRNAVal of the 
budding yeast, but similar pathways could exist for other tRNAs or different tRNAs 
could be targeted by such a pathway in other organisms like S. pombe.  
Studies on mRNA translation have revealed that the disruption of Trm4 function in 
S. cerevisiae leads to an increased sensitivity to the antibiotic paromomycin, which 
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affects the precision of ribosome decoding (Wu et al. 1998). This indicates that 
methylation of tRNAs could affect translation efficiency. 
Another interesting aspect of m5C in tRNAs has been described previously (Schaefer 
et al. 2010). Methylation by Dnmt2 protects Drosophila tRNAs against stress-induced 
cleavage and cleavage by angiogenin. This could also be the case for Pmt1 
substrates in S. pombe. There are several RNases annotated in the genome of the 
fission yeast and tRNA fragments have been implicated to be involved in several 
cellular processes (Thompson and Parker 2009; Phizicky and Hopper 2010; Ivanov 
et al. 2011). A modulation of tRNA fragments by modification of the tRNA could 
influence these processes. tRNAs were also shown to interact with cytochrome c and 
thus inhibit caspase activation (Mei et al. 2010). Whether this process might be 
influenced by methylation of the tRNAs is worth investigating. 
 
6.4 Nutrient components as a cause for changes in tRNA 
methylation 
A major discovery of this study was the induction of tRNA methylation levels upon 
addition of peptone to the medium. Peptone is an enzymatic digest of animal protein 
that serves as amino acid and nitrogen source in yeast cultures. A typical peptone 
contains small peptides (less than 15 % are larger than 5 kDa) and amino acids, but 
peptic digestion of animal tissue also leaves vitamins and growth factors in the 
mixture. The complex composition of this media component might be the reason for 
the strong effect that it has on tRNA methylation by Pmt1, and it will be interesting to 
identify a single component within the peptone mixture that induces Pmt1 activity.  
The natural habitat of Schizosaccharomyces pombe cells is the surface of several 
fruits. The nutrients that are available under such conditions vary significantly from 
the culture media that are used in the laboratory. Therefore, it is likely that protein 
expression and protein activity in laboratory strains differ from the situation in cells 
that grow in their natural environment. Thus, the inactivation of a protein as highly 
conserved during evolution as the Dnmt2 homolog Pmt1 in laboratory strains could 
be attributed to the altered requirements under the optimized growth conditions in the 
laboratory. The requirement for a possibly stabilizing tRNA modification like the 
methylation at cytosine 38 in tRNAAsp (Motorin et al. 2009) might also be reduced in a 
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complete medium like YES that provides the yeast cells with enough nutrients to 
replace degraded tRNAs.  
When peptone was added to the S. pombe complete medium (YES), Pmt1 was 
activated and tRNAAsp was methylated. In this modified medium, the cells still had all 
other nutrients that they also had in YES medium. Therefore, the cause for the 
activation of Pmt1 could not be the absence of required nutrients. It would rather be 
the presence of a component of peptone that induces Pmt1 activation. Whether this 
component activates or inactivates a cellular factor upstream of Pmt1 will be of 
interest in future experiments. Furthermore, it would be possible that the presence of 
this peptone component somehow mimics the nutrient availability in the natural 
environment of S. pombe. This would cause the cells to adapt the tRNA methylation 
levels to the ones needed in the natural habitat. This possible explanation needs 
further support and it would be important to determine the tRNA methylation state of 
cells that were isolated from their natural environment. 
A second explanation for tRNA methylation upon peptone addition might be that the 
cells are stressed by this media component in some way. Cellular stress can cause 
various changes in protein activity (Kourtis and Tavernarakis 2011). This assumption 
is supported by the observation that S. pombe cells are able to mate and sporulate 
on YPD medium. This process is usually induced under starvation conditions. This 
suggests that YPD might not really serve as a “complete medium” for S. pombe cells. 
Thus, it is possible that the cells undergo nutritional stress in this medium. Therefore, 
it is also plausible that the tRNA methylation level is increased by an altered Pmt1 
activity upon peptone addition as a means of cellular stress response.  
Independently of the cause, natural level or stress response, the methylation of tRNA 
molecules could contribute to the efficiency of protein translation either by enhanced 
recognition by the ribosome or by altered tRNA stability (Motorin et al. 2009; 
Schaefer et al. 2010).  
Another nutritional component that could be important for Dnmt2 function is glucose. 
Studies on the Entamoeba histolytica homolog of Dnmt2 revealed an interaction with 
the glycolytic enzyme enolase (Tovy et al. 2010b). Nuclear Dnmt2 is inhibited by the 
interaction with enolase upon glucose starvation, and this inhibition can be reversed 
by the enolase substrate 2-phosphoglycerate. These results indicate that glucose 
starvation might influence the methyltransferase activity of Dnmt2 enzymes, a fact 
that could also have an impact on caloric restriction effects in yeast cells. Low 
glucose growth conditions are known to influence aging in yeast cells due to the 
Discussion 
 86 
beneficial effects of caloric restriction on chronological lifespan (Smith et al. 2007). If 
low glucose levels would result in inhibition of Pmt1 activity in S. pombe cells, this 
would provide a possible explanation for the lifespan extension we observed in 
pmt1Δ cells. 
6.5 How does the serine/threonine kinase Sck2 influence Pmt1 
activity? 
During our study, we observed a reduction of Pmt1-dependent RNA methylation 
upon deletion of the serine/threonine kinase Sck2 (Fujita and Yamamoto 1998). 
These results suggested that Pmt1 activity was regulated either directly or indirectly 
via phosphorylation. We hypothesize that in the presence of Sck2, Pmt1 would be 
phosphorylated and fully active. Conversely, when Sck2 is missing, Pmt1 would not 
be phosphorylated, and the activity of Pmt1 would be reduced, but not completely 
inhibited. We did not determine whether this modulation of Pmt1 activity is carried out 
directly by Sck2 or by downstream targets that are activated by Sck2 (Zuin et al. 
2010). 
Next to other possible phosphorylation sites within Pmt1, an interesting target for 
phosphorylation by Sck2 would be the serine residue located next to the catalytic 
cysteine in motif IV (PSCQ). This serine residue represents a deviation from the 
consensus sequence of Dnmt2 enzymes. In the structure of Dnmt2, the catalytic 
cysteine in motif IV is situated in a loop (Dong et al. 2001). Due to the similarities in 
the amino acid sequence, we can assume that Pmt1 folds in a similar way as Dnmt2. 
This would imply that the serine residue in the Pmt1 sequence would also be located 
in this loop structure. Thus, it would be easily accessible for modification by Sck2. A 
phosphorylation right next to a catalytic amino acid side chain might influence the 
position of this side chain and could therefore also influence the activity of the 
enzyme. If the phosphorylation would shift the position of the cysteine closer to the 
substrate, this would provide a possible explanation for an increased activity of Pmt1 
upon phosphorylation by Sck2. 
A second residue that would be an interesting target for phosphorylation is the 
threonine in the target recognition motif. The CFT motif is well conserved among 
Dnmt2 enzymes (Dong et al. 2001), but is not found in other DNA methyl-
transferases. A phosphorylation at this site could influence the positioning of the 
target base within the catalytic pocket, which could increase the activity of Pmt1.  
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An interesting aspect of these two possible phosphorylation sites is that the first one 
is unique to Pmt1 and the second one is found in all Dnmt2 enzymes (Figure 7). 
Regulation at the serine that is unique to Pmt1 would be found exclusively in the 
S. pombe homolog, whereas regulation in the target recognition domain would then 
also be possible in the other Dnmt2 homologs.  
Apart from these considerations, analysis of potential phosphorylation sites by 
NetPhos (http://www.cbs.dtu.dk/services/NetPhos/ (Blom et al. 1999)) predicted 8 
serine phosphorylation sites, 4 threonine phosphorylation sites and one tyrosine 
phosphorylation site. Neither the serine residue in the catalytic motif IV nor the 
threonine in the target recognition motif were indicated as potential targets for 
phosphorylation, but interestingly the serine residue directly N-terminal to the 
catalytic motif PSCQ was identified as a candidate phosphorylation site. This residue 
was also identified as potential phosphorylation site by NetPhosYeast 
(http://www.cbs.dtu.dk/services/NetPhosYeast/ (Ingrell et al. 2007)). However, this 
prediction implied 11 serine phosphorylation sites that included the serine residue 
within the catalytic motif as target for phosphorylation, which supports the 
considerations on Pmt1 activity described above. This analysis tool did not predict 
any threonine phosphorylation sites. 
Taken together, Pmt1 activity could be regulated by posttranslational phosphorylation 
of a variety of potential target amino acids. This phosphorylation could be performed 
by the serine/threonine kinase Sck2 or by a downstream target of Sck2 signaling. 
  
6.6 How could rapamycin affect tRNA methylation by Pmt1? 
When we treated S. pombe cells with rapamycin, we observed a reduction of the 
Pmt1-mediated methylation signal in the in vitro methylation assay. In other 
experiments, we always interpreted reduced signal strength as an indicator for an 
increased in vivo methylation of the RNA substrates of Pmt1. However, when we 
treated pmt1Δ cells with rapamycin, we also observed a reduction of the 
autoradiography signal. Due to the absence of Pmt1 in these cells, a reduction of the 
signal in pmt1Δ cells is unlikely to represent an increased methylation in the cells. 
Therefore, we asked what other explanations there might be for a decrease in signal 
strength after in vitro methylation of total RNA extracts.  
Discussion 
 88 
One reason for this could be that upon treatment with rapamycin, another m5C 
methyltransferase becomes activated and starts methylating Pmt1 target sites. Since 
there is no other Dnmt2 homolog annotated in the fission yeast genome, this 
methyltransferase could only be an RNA methyltransferase. Trm4 performs 
methylation at position 5 of cytosines in tRNAs of Saccharomyces cerevisiae, and 
there are two putative Trm4-homologs annotated in the S. pombe genome 
(SPAC17D4.04, SPAC23C4.17). However, Trm4 has only been shown to methylate 
the positions 48 and 49 in the T-stem, position 40 in the anticodon stem and position 
34 in the anticodon loop of various tRNAs in S. cerevisiae (Motorin and Grosjean 
1999), but has never been associated with methylation of position C38 in the 
anticodon loop.  
On the other hand, a reduced in vitro methylation could also be explained by the 
absence of target tRNAs in the total RNA extracts. The EtBr staining in these 
experiments confirmed that an equal amount of total RNA was used in the control 
reaction as well as in the reaction with RNA from rapamycin treated cells. Therefore, 
the reduced signal is not due to reduction of global RNA amount. However, it is 
possible that within the bulk of small RNAs that comprise the RNA band containing 
tRNAAsp, the amount of Pmt1 substrate is decreased. In a mixture of tRNAs, the 
absence of one tRNA species cannot be observed by EtBr staining. In this scenario, 
a reduced amount of Pmt1 substrates in the total RNA could be explained by a 
specific cleavage or degradation of unmethylated Pmt1 substrates. This degradation 
would be induced by the addition of rapamycin and would probably be indirect and 
mediated by an inhibition of the TOR complex (Heitman et al. 1991). 
Addition of rapamycin could also be responsible for a reduced level of tRNA 
transcription. It has been shown that mTOR binds to tRNA genes and thus controls 
tRNA synthesis via inhibition of the RNA polymerase III inhibitor Maf1 (Kantidakis et 
al. 2010; Tsang et al. 2010). In this scenario, inhibition of Tor could result in inhibition 
of tRNA transcription and subsequent reduction of cellular tRNA levels. The reduced 
tRNA levels would then be detected as reduced in vitro methylation signals in the 
methylation assay that was used in our study, regardless of the presence of Pmt1. 
To determine which of the discussed possibilities is the probable cause for our 
observations, this has to be the subject of further investigations. The activation of a 
C38 methylation activity of Trm4 homologs would be supported by the broad 
spectrum of target sites and RNA substrates of these methyltransferases. Substrate 
degradation, on the other hand, would be in agreement with the protection of Dnmt2 
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substrates against cleavage by the RNase angiogenin (Schaefer et al. 2010). If an 
RNase is activated upon rapamycin treatment, the unmethylated Pmt1 substrates of 
a pmt1Δ strain would be degraded. The inhibition of tRNA translation, as a third 
possibility, could be determined by Northern Blot analysis. 
 
6.7 Pmt1-dependent tRNA methylation and chronological aging 
The results of this study provided evidence for a role of Pmt1 activity in the 
chronological aging process in fission yeast. We were able to show that the deletion 
of the pmt1+ gene elongated the lifespan of S. pombe cells when they were cultured 
in minimal medium (EMM). This is contradictory to the data that were obtained from 
Drosophila. Fruit flies were shown to have a shortened lifespan upon disruption of 
Dnmt2 function (Lin et al. 2005; Schaefer et al. 2010). This points towards an 
interesting species-specific difference in the control of lifespan. Combined with the 
observation that Pmt1 activity is partially regulated by the serine/threonine kinase 
Sck2, this led us to hypothesize that sck2Δ-mediated lifespan extension (Roux et al. 
2006) can at least partially be attributed to reduced Pmt1 activation in sck2Δ cells. 
However, equivalent aging experiments in complete medium containing peptone 
(YPD), which activates Pmt1-dependent tRNA methylation, displayed an elongated 
lifespan of the wild-type strain. As we were able to show, wild-type cells carry 
completely methylated tRNAAsp under these culture conditions. Therefore, the results 
from the second aging experiment were in conflict with the results obtained in 
minimal medium. However, it is not unprecedented that aging effects depend on 
media conditions. For instance, different minimal media were demonstrated to 
influence chronological lifespan and alter the effects of caloric restriction in S. pombe 
(Chen and Runge 2009). 
We speculated that nutrient availability might influence the requirement of tRNA 
methylation for the cellular aging process. Longevity in complete medium might thus 
require methylation of tRNAAsp, whereas it can be omitted in minimal medium. The 
conditions in minimal medium might render the aging process such that it requires 
the resources needed for tRNA methylation in other cellular processes that are more 
important for survival than tRNA methylation. In this case, the absence of a tRNA 
methylation process would be beneficial for cell survival. In complete medium these 
resources could be obtained from the medium, and the presence of the tRNA 
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methylation machinery would not disrupt other processes required for cell survival. In 
such a case, tRNA methylation could provide a minor beneficial effect on cellular 
aging, possibly through increased tRNA stability, protection against cleavage or other 
regulatory functions that might be unrelated to the tRNA function in protein 
translation.  
The nutritional status and nutritional stress response have been implicated in the 
regulation of tRNA localization (Huynh et al. 2010). The nuclear reexport of mature 
tRNAs into the cytoplasm is mediated by the amino acid-sensitive tRNA exporter 
Xpo-t. We could therefore also hypothesize that the different nutrient conditions in the 
minimal media could induce nuclear accumulation of unmethylated charged tRNAs 
upon aging and thus prevent the amino acids that are bound to the tRNAs to act as 
activators of the TOR complex (Sancak et al. 2008). Reduced TOR activity would 
then result in an increased lifespan. However, to date there are no indications for an 
influence of tRNA methylation on nuclear reexport of tRNAs, which might be an 
interesting aspect of further research. 
 
6.8 Is Pmt1-dependent tRNA methylation an isolated process? 
During the course of this study, we failed to identify direct or synthetic lethal 
interaction partners of Pmt1. Do these observations suggest that Pmt1 does not 
interact with other proteins or that there are no pathways that act in parallel to Pmt1? 
Our own results on Pmt1 regulation by Sck2 suggest otherwise. No matter if the 
regulation is directly through Sck2 or if a downstream target of Sck2 regulates Pmt1 
activity, it is likely that the regulation is done by posttranslational modification of the 
Pmt1 protein. This requires physical contact of the modifying enzyme and Pmt1, and 
therefore suggests that there are physical interaction partners of Pmt1. We also 
demonstrated that the activity of Pmt1 was altered by the applied culture medium. 
Therefore, protein interactions might occur when cells cultured in YPD medium are 
used for protein purification, whereas the purifications here were performed in YES 
medium.  
The same is true for synthetic lethal interaction partners that could point towards 
pathways that act parallel to Pmt1. The interaction might only be essential under 
conditions that require Pmt1-dependent tRNA methylation. Therefore, it seems to be 
promising to include the new knowledge on Pmt1 activation in YPD medium in the 
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strategy to identify synthetic lethal interactions. The identification of both physical 
interaction partners and synthetic lethal interactions will provide valuable insight into 
the biological function of Pmt1 and might provide data that place Pmt1 into known 
signaling pathways. 
 
6.9 The impact of this study on previous observations 
concerning Pmt1 
A major aspect of the investigation of Pmt1 activity in the fission yeast was the 
apparent absence of detectable DNA methylation despite the presence of a putative 
DNA methyltransferase (Antequera et al. 1984). These results were obtained from 
yeast cells cultured in a medium that does not induce Pmt1 activity (2 % yeast 
extract, 2 % glucose). Combined with observations from other Dnmt2 homologs that 
display a low DNA methyltransferase activity (Hermann et al. 2003; Kuhlmann et al. 
2005), this suggests that in vivo Pmt1 activity on DNA substrates should be 
reinvestigated under inducing conditions. Other studies reported that recombinant 
Pmt1 was unable to methylate DNA substrates (Wilkinson et al. 1995; Pinarbasi et al. 
1996), but our discovery of a possible regulation of Pmt1 activity by phosphorylation 
could indicate that the recombinant protein lacks the essential activating 
phosphorylation. Comparison of phosphorylation site prediction from NetPhosYeast 
(Ingrell et al. 2007) and NetPhosBac (http://www.cbs.dtu.dk/services/NetPhosBac-
1.0/ (Miller et al. 2009)), a predictor for bacterial phosphorylation sites, revealed that 
only 5 out of 11 phosphorylation sites predicted by NetPhosYeast were also included 
in the prediction from NetPhosBac. Significantly, the interesting phosphorylation sites 
in motif IV are absent in the NetPhosBac prediction. This could indicate that essential 
modifications for Pmt1 activation are missing in the recombinant protein. Taken 
together, our study revealed the possibility that the absence of DNA 
methyltransferase activity of Pmt1 could be due to a lack of phosphorylation under 
the previously investigated conditions and supports a reinvestigation of this DNA 
methyltransferase activity, both in vitro and in vivo. 
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7 Outlook 
In this study, we have investigated the Dnmt2 homolog Pmt1 from fission yeast and 
have found that Pmt1 is an active tRNA methyltransferase, and that it is activated 
under certain nutritional conditions. The activity of the enzyme is partially regulated 
by the serine/threonine kinase Sck2 and might be an effector of Sck2-mediated 
lifespan extension, because we observed an elongated lifespan upon deletion of 
pmt1+. The results of this project open up several possibilities for gaining further 
insight into the activity and biological function of Pmt1. 
We found Pmt1 to be activated by addition of peptone to S. pombe complete 
medium. Furthermore, 25 % tRNAAsp methylation was observed in cells cultured in 
minimal medium. In the future, the conditions leading to Pmt1 activation could be 
further refined by the identification of distinct compounds that activate the enzyme. 
For this purpose, minimal medium lacking individual components could be used to 
culture S. pombe cells, and RNA bisulfite sequencing and in vitro methylation of total 
RNA extracts by recombinant Pmt1 could then be used to determine tRNA 
methylation levels. The effect of excess amounts of these nutritional components 
could additionally be analyzed. Time course experiments upon switching cells from 
inducing medium to non-inducing medium and vice versa will provide essential 
information on the establishment and persistence of the tRNA methylation mark. 
Assuming that reduced nutrient availability provides a stress condition for the cells, 
the influence of various stresses like heat stress and oxidative stress could also be 
investigated. 
The nutrient dependency of Pmt1 activity also sheds new light on previous results on 
the genome-wide DNA methylation activity of Pmt1. DNA bisulfite sequencing could 
be employed to identify DNA methylation in cells cultured under inducing conditions. 
Additionally, our results on physical and synthetic lethal interaction partners have to 
be reevaluated by application of inducing conditions in the respective experiments. 
Our observation that Sck2 is required for Pmt1 activity suggests that Pmt1 may be a 
phosphorylation target. This could be investigated by mass spectrometry of Pmt1 
protein that has been purified from S. pombe cells. Furthermore, site-directed 
mutagenesis could be utilized to analyze the impact of putative phosphorylation sites. 
Mutation to alanine would render the putative phosphorylation sites unmodifiable, 
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and the impact of these mutants on tRNA methylation could be determined via RNA 
bisulfite sequencing or in vitro methylation by recombinant Pmt1/Pmt1 mutants.  
The results of this work not only implicate modifications on the protein level, but they 
also suggest that the substrate tRNAs may be targeted by certain degradation 
pathways. The impact of rapamycin on the results of the in vitro methylation assay 
suggested that specific RNases could degrade unmethylated Pmt1 substrates upon 
rapamycin treatment. This could be due to cleavage of the tRNAs in the anticodon 
loop. To test this, Northern blot analysis could identify tRNA fragments. If these 
fragments can be identified, the next step would be to determine the RNase 
responsible for the cleavage. For this purpose, candidate RNases could be deleted in 
the S. pombe cells and the double mutant lacking both Pmt1 and the RNase should 
display the same in vitro tRNA methylation levels as untreated pmt1Δ cells, when 
they are treated with increasing amounts of rapamycin. Northern Blot analysis could 
also be utilized for the investigation of changes in the RNA transcription level, when 
RNases were inhibited in the cell culture.  
Another important finding of this study was the lifespan alterations in pmt1Δ cells. 
Future experiments could be designed to investigate if Pmt1 activity is involved in the 
lifespan regulation by other factors known to be involved in aging like sirtuins 
(Kaeberlein 2010), the TOR pathway (Sharp and Richardson 2011) or the glucose 
sensing pathway (Roux et al. 2006). The combination of pmt1Δ with other lifespan 
extending mutants could place Pmt1 in one of these pathways. 
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8 Abstract 
DNA nucleotide methyltransferases (Dnmts) are the enzymes responsible for the 
conversion of cytosine to 5-methylcytosine in eukaryotes. The fission yeast 
Schizosaccharomyces pombe contains a putative DNA methyltransferase, termed 
pombe methyltransferase1 (Pmt1) that belongs to the Dnmt2 family of cytosine 
methyltransferases, but intriguingly has no DNA methylation. Dnmt2 family members 
from several organisms have been demonstrated to methylate tRNAAsp at position 
C38 rather than cytosines in DNA, but the biological function of this tRNA 
modification has remained largely unknown.  
In this study, we found that Pmt1 is able to methylate position C38 of tRNAAsp and to 
a lesser extent tRNAGlu in vitro using methylation of tRNA transcripts by recombinant 
Pmt1. RNA bisulfite sequencing of tRNAs showed that Pmt1 is also active in vivo. 
These results show that mt1 in principle has methyltransferase activity, although it 
was previously thought to be inactive due to a deviation in catalytic motif IV from 
other Dnmt2 enzymes. Furthermore, in vivo Pmt1 activity was strongly influenced by 
a nutritional factor in the growth medium. Induction of Pmt1 methyltransferase activity 
was observed upon the addition of peptone to S. pombe growth medium. 
Furthermore, the induction of Pmt1 activity required the serine/threonine kinase Sck2 
and was independent of the kinases Sck1, Pka1 and Tor1. Significantly, cells with full 
tRNA methylation displayed a shortened chronological lifespan, whereas the deletion 
of pmt1+ lead to an elongated lifespan in fission yeast. 
In summary, out data show that Pmt1 is an active tRNA methyltransferase. 
Furthermore, Pmt1 function is regulated in a nutrient-dependent manner by the 
serine/threonine kinase Sck2, and it is involved in the regulation of chronological 
aging in the fission yeast Schizosaccharomyces pombe. 
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9 Zusammenfassung 
DNA Methyltransferasen (Dnmts) in Eukaryoten katalysieren die Umwandlung von 
Cytosin zu 5-Methylcytosin. Die Spalthefe Schizosaccharomyces pombe besitzt eine 
mögliche DNA Methyltransferase namens Pombe Methyltransferase1 (Pmt1), die zur 
Familie der Dnmt2 Enzyme gehört, besitzt jedoch keine nachweisbare DNA 
Methylierung. Dnmt2 Homologe aus verschiedenen Organismen sind in der Lage, 
tRNAAsp an Position C38 zu methylieren und zeigen vergleichsweise geringe DNA 
Methylierungsaktivität. Die biologische Funktion dieser tRNA-Modifikation ist bisher 
kaum erforscht.  
Unsere Ergebnisse aus in vitro Methylierungsanalysen mit rekombinantem Pmt1 
zeigen, dass das S. pombe Homologe von Dnmt2 in der Lage ist, tRNAAsp und 
tRNAGlu aus der Spalthefe zu methylieren. Diese Resultate demonstrieren, dass 
Pmt1 ein aktives Enzym ist, obwohl frühere Untersuchungen nahe legten, dass eine 
Abweichung von der Konsensussequenz der Dnmt2 Enzyme im katalytischen 
Motiv IV zu einer Inaktivierung des Enzyms geführt hat. Mittels der RNA Bisulfit-
Sequenzierung konnten wir diese Aktivität auch in vivo zeigen. Interessanterweise 
zeigten unsere Untersuchungen, dass die Aktivität von Pmt1 durch die Nährstoffe im 
Kultivierungsmedium reguliert wird. Die Methyltransferaseaktivität von Pmt1 wurde 
induziert, wenn dem S. pombe Vollmedium Pepton zugesetzt wurde. Des Weiteren 
konnten wir zeigen, dass für die Induktion der Pmt1-Aktivität die Serin/Threonin-
Kinase Sck2 benötigt wird, wohingegen die Kinasen Sck1, Pka1 und Tor1 keinen 
Einfluß auf die Pmt1-abhängige tRNA-Methylierung hatten. Schließlich konnten wir 
außerdem zeigen, dass Hefezellen, die eine starke tRNA-Methylierung aufweisen, 
eine verkürzte chronologische Lebensspanne besitzen. Die Deletion des pmt1+-Gens 
führt hingegen zu einer Verlängerung der Lebensspanne der S. pombe Zellen. 
Zusammengefasst zeigen unsere Daten, dass Pmt1 eine aktive tRNA 
Methyltransferase ist, dass die Funktion von Pmt1 nährstoffabhängig von der 
Serin/Threonin kinase Sck2 reguliert wird, und dass Pmt1 an der Regulation der 
chronologischen Alterung in der Spalthefe Schizosaccharomyces pombe beteiligt ist.  
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